Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	microtubule-based movement	ING2 IFT172 FYCO1 AKAP4 GK2 KIF3B SYNE2 KIF19 VPS13A AP3D1 FLOT2 ANK3 DYNC2H1 ANXA5 APBA1 CILK1 ARMCX3 RGN CELSR2 CATSPER2 DYNLT5 DNAH11	1.66e-06	493	286	22	GO:0007018
GeneOntologyBiologicalProcess	organelle assembly	IFT172 TTC39C SPTBN2 SYNPO2L OBSCN RABGAP1 TBC1D20 TBC1D16 CSDE1 AKAP4 GK2 KIF3B MYOZ1 ANLN SYNE2 MYPN ASPM AP3D1 MRM2 DYNC2H1 ATG2B CILK1 PTPN23 LMOD2 SHANK3 GTF2B TBC1D31 CELSR2 SPACA1 CCNB2 PRKAA1 PRKAR1A ATM IL1RAP	2.14e-05	1138	286	34	GO:0070925
GeneOntologyCellularComponent	glutamatergic synapse	GABRG2 MYO6 SPTBN2 PHB2 SEMA4C KIF3B AP2B1 SCN10A PLEKHA5 AP3D1 PRUNE2 CACNA1A CACNA1B ANO2 FLOT2 CALD1 APBA1 DGKZ GRID1 GRM1 GPC6 SHANK3 ARHGEF15 ATAD1 PRKAR1A DGKI CTNND1 IL1RAP TNR CDH11 ARHGAP33 CPEB1	1.57e-07	817	292	32	GO:0098978
GeneOntologyCellularComponent	Z disc	SYNPO2L OBSCN AKAP4 MYOZ1 SCN1A SYNE2 MYPN ANK3 ANXA5 JPH2	5.37e-05	151	292	10	GO:0030018
GeneOntologyCellularComponent	I band	SYNPO2L OBSCN AKAP4 MYOZ1 SCN1A SYNE2 MYPN ANK3 ANXA5 JPH2	1.19e-04	166	292	10	GO:0031674
GeneOntologyCellularComponent	myofibril	SYNPO2L OBSCN AKAP4 MYOZ1 SCN1A SYNE2 MYPN SIMC1 CALD1 ANK3 ANXA5 JPH2 LMOD2	1.31e-04	273	292	13	GO:0030016
GeneOntologyCellularComponent	sarcomere	SYNPO2L OBSCN AKAP4 MYOZ1 SCN1A SYNE2 MYPN SIMC1 ANK3 ANXA5 JPH2 LMOD2	2.12e-04	249	292	12	GO:0030017
GeneOntologyCellularComponent	contractile muscle fiber	SYNPO2L OBSCN AKAP4 MYOZ1 SCN1A SYNE2 MYPN SIMC1 CALD1 ANK3 ANXA5 JPH2 LMOD2	2.37e-04	290	292	13	GO:0043292
GeneOntologyCellularComponent	Bcl-2 family protein complex	BAX BCL2 BIK	3.01e-04	10	292	3	GO:0097136
GeneOntologyCellularComponent	Schaffer collateral - CA1 synapse	MYO6 CACNA1B APBA1 DGKZ GRM1 DGKI CTNND1 TNR CDH11	3.40e-04	155	292	9	GO:0098685
GeneOntologyCellularComponent	postsynapse	GABRG2 MYO6 SPTBN2 PHB2 PAK6 CYP46A1 SEMA4C KIF3B AP2B1 PLEKHA5 DAGLA AP3D1 CACNA1A CALD1 ANK3 MINK1 APBA1 DGKZ GRID1 GRM1 SHANK3 ARHGEF15 ATAD1 DGKI MACF1 CTNND1 ARHGAP33 CPEB1	5.15e-04	1018	292	28	GO:0098794
GeneOntologyCellularComponent	organelle outer membrane	PHB2 BAX BCL2 GK2 SYNE2 VPS13A CASP8 CPT1A ARMCX3 KMO ATAD1 QTRT1	5.91e-04	279	292	12	GO:0031968
GeneOntologyCellularComponent	mitochondrial outer membrane	PHB2 BAX BCL2 GK2 VPS13A CASP8 CPT1A ARMCX3 KMO ATAD1 QTRT1	6.09e-04	241	292	11	GO:0005741
GeneOntologyCellularComponent	outer membrane	PHB2 BAX BCL2 GK2 SYNE2 VPS13A CASP8 CPT1A ARMCX3 KMO ATAD1 QTRT1	6.29e-04	281	292	12	GO:0019867
GeneOntologyCellularComponent	postsynaptic density	MYO6 PHB2 PAK6 SEMA4C PLEKHA5 DAGLA ANK3 MINK1 DGKZ GRID1 GRM1 SHANK3 DGKI MACF1 CTNND1 CPEB1	6.51e-04	451	292	16	GO:0014069
GeneOntologyCellularComponent	postsynaptic specialization	GABRG2 MYO6 PHB2 PAK6 SEMA4C PLEKHA5 DAGLA ANK3 MINK1 DGKZ GRID1 GRM1 SHANK3 DGKI MACF1 CTNND1 CPEB1	7.64e-04	503	292	17	GO:0099572
GeneOntologyCellularComponent	axon	GABRG2 MYO6 CYP17A1 GARS1 PHB2 KIF3B SACS SCN1A MYPN SCN10A DAGLA AP3D1 SLC12A6 CACNA1B ANK3 ANXA5 MINK1 GRM1 ARMCX3 SPTBN4 PRKAA1 DGKI WDFY3 CTNND1 CPEB1	7.76e-04	891	292	25	GO:0030424
GeneOntologyCellularComponent	cilium	FBXL13 RIBC2 PSG6 IFT172 AKAP4 GK2 KIF3B KIF19 VPS13A PKD1 STOML3 TBCC STRCP1 ANO2 DYNC2H1 KIAA1549 CILK1 PTPN23 CCT4 SHANK3 TBC1D31 CATSPER2 TTLL11 PRKAR1A DNAH11	8.66e-04	898	292	25	GO:0005929
GeneOntologyCellularComponent	somatodendritic compartment	GABRG2 MYO6 CYP17A1 SPTBN2 SST CYP46A1 KIF3B SACS SCN1A VPS13A DAGLA CACNA1A CACNA1B FLOT2 CALD1 ANK3 PLXDC1 ANXA5 MINK1 APBA1 GRM1 SHANK3 ARHGEF15 SPTBN4 GAL PRKAA1 DGKI WDFY3 CTNND1 ARHGAP33 CPEB1	1.07e-03	1228	292	31	GO:0036477
GeneOntologyCellularComponent	neuron to neuron synapse	MYO6 PHB2 PAK6 SEMA4C PLEKHA5 DAGLA ANK3 MINK1 DGKZ GRID1 GRM1 SHANK3 DGKI MACF1 CTNND1 TNR CPEB1	1.17e-03	523	292	17	GO:0098984
GeneOntologyCellularComponent	asymmetric synapse	MYO6 PHB2 PAK6 SEMA4C PLEKHA5 DAGLA ANK3 MINK1 DGKZ GRID1 GRM1 SHANK3 DGKI MACF1 CTNND1 CPEB1	1.17e-03	477	292	16	GO:0032279
GeneOntologyCellularComponent	microtubule organizing center	FBXL13 DIS3L IFT172 RABGAP1 BIRC6 USP20 KIF3B CROCC2 ASPM CCDC14 CCHCR1 CCDC22 UBR4 TRIOBP CILK1 PTPN23 CCT4 TEK TBC1D31 PLEKHG6 CCNB2 TTLL11 PRKAR1A ATM CPEB1	1.20e-03	919	292	25	GO:0005815
GeneOntologyCellularComponent	cell-cell junction	EPPK1 PSG6 SPTBN2 MTSS1 SH3BP1 OBSCN GJA4 SCN1A FLOT2 ANK3 PLXDC1 SGCA ANXA5 TEK SPTBN4 PCDHGA12 CTNND1 CDH11	1.74e-03	591	292	18	GO:0005911
MousePheno	abnormal nervous system electrophysiology	GABRG2 MYO6 SPTBN2 GARS1 SST SCN1A SCN10A STOML3 DAGLA AP3D1 CACNA1A SLC12A6 CACNA1B ANK3 LAMB1 GPRIN3 GRM1 SHANK3 TNR	2.18e-06	329	230	19	MP:0002272
Domain	ARM-type_fold	USP34 IFT172 TRRAP LYST AP2B1 ASPM MROH7 GCN1 TARBP1 AP3D1 IPO5 MROH2A UBR4 ARMCX3 THADA ELMO2 HEATR9 INTS4 ATM WDFY3 CTNND1 IPO11	1.23e-08	339	284	22	IPR016024
Domain	ARM-like	TRRAP AP2B1 ASPM MROH7 GCN1 TARBP1 AP3D1 IPO5 MROH2A ARMCX3 ELMO2 HEATR9 INTS4 WDFY3 CTNND1 IPO11	4.09e-06	270	284	16	IPR011989
Domain	-	TRRAP AP2B1 ASPM MROH7 GCN1 AP3D1 IPO5 ARMCX3 ELMO2 HEATR9 INTS4 WDFY3 CTNND1 IPO11	8.13e-06	222	284	14	1.25.10.10
Domain	PH_dom-like	SPTBN2 OBSCN RABGAP1 NIBAN3 LYST ANLN PLCL2 PLEKHA5 AKT3 PLEKHG4 RANBP3 APBA1 TRIOBP ARHGEF15 SPTBN4 PLEKHG6 ELMO2 WDFY3 SNTB1	3.06e-05	426	284	19	IPR011993
Domain	HEAT_REPEAT	MROH7 GCN1 AP3D1 IPO5 MROH2A INTS4 IPO11	9.23e-05	70	284	7	PS50077
Domain	Bcl2_BH3_motif_CS	BAX BCL2 BIK	1.84e-04	8	284	3	IPR020728
Domain	HAD-like_dom	ATP9B ACAD10 ATP9A ATP10D ATP2C1 NT5C2 ATP2A3	1.99e-04	79	284	7	IPR023214
Domain	ATPase_P-typ_P_site	ATP9B ATP9A ATP10D ATP2C1 ATP2A3	2.01e-04	36	284	5	IPR018303
Domain	P_typ_ATPase	ATP9B ATP9A ATP10D ATP2C1 ATP2A3	2.01e-04	36	284	5	IPR001757
Domain	ATPASE_E1_E2	ATP9B ATP9A ATP10D ATP2C1 ATP2A3	2.01e-04	36	284	5	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP9B ATP9A ATP10D ATP2C1 ATP2A3	2.30e-04	37	284	5	IPR008250
Domain	E1-E2_ATPase	ATP9B ATP9A ATP10D ATP2C1 ATP2A3	2.30e-04	37	284	5	PF00122
Domain	-	SPTBN2 OBSCN RABGAP1 NIBAN3 ANLN PLCL2 PLEKHA5 AKT3 PLEKHG4 RANBP3 APBA1 TRIOBP SPTBN4 PLEKHG6 ELMO2 SNTB1	3.42e-04	391	284	16	2.30.29.30
Domain	PH	SPTBN2 OBSCN NIBAN3 ANLN PLCL2 PLEKHA5 AKT3 PLEKHG4 TRIOBP SPTBN4 PLEKHG6 ELMO2 SNTB1	3.52e-04	278	284	13	SM00233
Domain	Spectrin	SPTBN2 SYNE2 SPTBN4 MACF1	3.69e-04	23	284	4	PF00435
Domain	ACTININ_2	SPTBN2 SYNE2 SPTBN4 MACF1	3.69e-04	23	284	4	PS00020
Domain	ACTININ_1	SPTBN2 SYNE2 SPTBN4 MACF1	3.69e-04	23	284	4	PS00019
Domain	Actinin_actin-bd_CS	SPTBN2 SYNE2 SPTBN4 MACF1	3.69e-04	23	284	4	IPR001589
Domain	PH_domain	SPTBN2 OBSCN NIBAN3 ANLN PLCL2 PLEKHA5 AKT3 PLEKHG4 TRIOBP SPTBN4 PLEKHG6 ELMO2 SNTB1	3.76e-04	280	284	13	IPR001849
Domain	Band_7	PHB2 STOML3 FLOT2	5.24e-04	11	284	3	PF01145
Domain	Band_7	PHB2 STOML3 FLOT2	5.24e-04	11	284	3	IPR001107
Domain	PHB	PHB2 STOML3 FLOT2	5.24e-04	11	284	3	SM00244
Pathway	BIOCARTA_MITOCHONDRIA_PATHWAY	BAX BCL2 BIK CASP8 XIAP	7.87e-06	19	216	5	M16257
Pathway	KEGG_APOPTOSIS	BAX BCL2 AKT3 CASP8 XIAP PRKAR1A ATM IL1RAP	5.52e-05	87	216	8	M8492
Pathway	WP_LIPID_METABOLISM_PATHWAY	ACACA ACSBG1 AKT3 PRKAA1 PRKAR1A	7.09e-05	29	216	5	M39762
Pathway	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	SPTBN2 SCN1A SCN10A ANK3 SPTBN4	9.90e-05	31	216	5	M877
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ACACA MYO6 EXPH5 SPTBN2 OBSCN ACTL6A TRRAP NCBP3 DDX46 COPS8 CROCC2 KIF19 ASCC2 PLEKHA5 QARS1 TOP3B AP3D1 GNL3L ANK3 KMO SART1 P4HA1 ATM CTNND1 ATP2A3 IPO11	1.67e-13	497	292	26	36774506
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYO6 DIS3L RASSF2 EXPH5 SPTBN2 BIRC6 USP20 SEMA4C SACS TXNDC16 PRUNE2 DYNC2H1 COBLL1 CILK1 PTPN23 GPRIN3 KIAA1191 SHANK3 WDR59 ARHGEF15 THADA ATP2C1 MACF1 KDM2A LRRC14	9.89e-13	493	292	25	15368895
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SPTBN2 SH3BP1 PHB2 FYCO1 KIF3B AP2B1 SYNE2 PLEKHA5 TOP3B CARM1 CACNA1A ANK3 MINK1 UBR4 PAK5 NSD1 TRIOBP DGKZ CCT4 GRM1 SHANK3 SPTBN4 SART1 AGO1 CELSR2 NT5C2 PRKAR1A DGKI MACF1 WDFY3 CTNND1 TNR CDH11	1.01e-11	963	292	33	28671696
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ACACA MYO6 GARS1 PHB2 ACTL6A TRRAP BIRC6 CSDE1 LONP1 AP2B1 ANLN SERPINB3 CPNE3 ASPM PLEKHA5 QARS1 GCN1 AP3D1 CCDC22 GNL3L PLEKHG4 ANXA5 UBR4 SAE1 CASP8 PTPN23 CCT4 LBR WDR59 SART1 CHTF18 MDC1 RCL1 MACF1 KDM2A WDFY3 CTNND1	3.22e-10	1353	292	37	29467282
Pubmed	A human MAP kinase interactome.	MYO6 EXPH5 SPTBN2 PAK6 CSDE1 SETDB1 AP2B1 SIMC1 PLEKHA5 GCN1 CCDC14 ANK3 COBLL1 PAK5 LAMB1 PTPN23 PRKAR1A MACF1 KDM2A MAP3K21 ARHGAP33	1.25e-09	486	292	21	20936779
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	USP34 BIRC6 SYNE2 PLEKHA5 GCN1 DAGLA PRUNE2 TRIOBP PTPN23 ARHGEF15 RBM12 MACF1 KDM2A WDFY3	8.43e-09	225	292	14	12168954
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GABRG2 MYO6 SPTBN2 PHB2 CSDE1 LONP1 TTC7B AP2B1 SACS HECW2 PLEKHA5 DAGLA SLC25A23 AP3D1 IPO5 CACNA1A SLC12A6 FLOT2 CALD1 ANK3 MINK1 KIAA1549 DGKZ CCT4 ATP9A GRM1 SHANK3 SPTBN4 AGO1 PRKAA1 PRKAR1A MACF1 CTNND1 TNR DNAH11	1.73e-08	1431	292	35	37142655
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ZNF609 SPTBN2 BAX DBT BIRC6 LONP1 TTC7B GSE1 SYNE2 PLCL2 VPS13A GCN1 TOP3B CCDC14 CCDC22 ANK3 MINK1 TRIOBP KIAA1549 PTPN23 GPRIN3 CCT4 PPEF1 TBC1D31 P4HA1 CCNB2 INTS4 CTNND1 SNTB1	2.41e-08	1049	292	29	27880917
Pubmed	A protein interaction landscape of breast cancer.	EPPK1 MYO6 SPTBN2 GARS1 ACTL6A JARID2 LONP1 AP2B1 COPS8 HPRT1 IPO5 FLOT2 AKT3 CALD1 ANK3 ANXA5 UBR4 CASP8 ATP2C1 CCNB2 MACF1 CTNND1	2.67e-08	634	292	22	34591612
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	ZNF609 POP4 MYO6 DIS3L GARS1 FYCO1 ASCC2 PLEKHA5 CHPF2 GCN1 CCHCR1 CCDC22 SAE1 ARMCX3 WDR59 ATP2C1 DTWD2 ATAD1 P4HA1 PRKAR1A INTS4 FUT8 QTRT1 IPO11	3.13e-08	754	292	24	33060197
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GABRG2 ACACA PDK3 PHB2 RABGAP1 DBT BIRC6 CSDE1 LONP1 ACSBG1 HPRT1 SCN1A GCN1 CACNA1A CACNA1B FLOT2 ANK3 MINK1 UBR4 ATG2B APBA1 TRIOBP CCT4 SHANK3 ATP2C1 CELSR2 ATAD1 PRKAR1A MACF1 CTNND1	3.97e-08	1139	292	30	36417873
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MYO6 PDK3 SPTBN2 PHB2 DBT TMCC3 NCBP3 SACS SYNE2 VPS13A ASPM ASCC2 PLEKHA5 TOP3B AP3D1 FLOT2 ANK3 DYNC2H1 RANBP3 MINK1 UBR4 TRIOBP KIAA1549 LAMB1 LBR NBAS THADA TBC1D31 P4HA1 RCL1 PRKAR1A MACF1 ATM CTNND1 SNTB1	4.44e-08	1487	292	35	33957083
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ACACA SPTBN2 ACTL6A TRRAP CSDE1 DDX46 ANLN PLEKHA5 GCN1 CCDC22 CALD1 ANK3 RANBP3 ATG2B NSD1 PTPN23 YEATS2 MDC1 KDM2A CTNND1	5.32e-08	549	292	20	38280479
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ACACA DIS3L SPTBN2 DBT CSDE1 LONP1 STXBP2 SIMC1 CPNE3 CCDC14 CCHCR1 FLOT2 CCDC22 CALD1 ZNF507 CASP8 CILK1 PTPN23 XIAP CCT4 KIAA1191 AGO1 TBC1D31 ELMO2 CCNB2	7.81e-08	853	292	25	28718761
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF609 SGSM1 ACACA MYO6 OBSCN ATP9B RABGAP1 TRRAP CSDE1 DAGLA RPS6KL1 PRUNE2 SLC12A6 GNL3L CALD1 ANK3 MINK1 GPATCH2 TRIOBP CILK1 XIAP CPT1A ADGRG6 SPTBN4 YEATS2 THADA ATP2C1 FAM13A TTLL11 NT5C2 CDYL2 MACF1 KDM2A CTNND1	1.43e-07	1489	292	34	28611215
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SPTBN2 PHB2 ACTL6A DBT TRRAP DDX46 AP2B1 SACS CPNE3 CPNE1 GCN1 AP3D1 PLXNB1 FLOT2 ANXA5 TRIOBP TRIM71 LBR GPC6 SART1 AGO1 CATSPER2 P4HA1 RCL1 INTS4 MACF1 ATM ARHGAP33	1.65e-07	1082	292	28	38697112
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	EPPK1 PDK3 PHB2 TMCC3 ACSBG1 DAGLA AP3D1 PDCD6 KIAA1549 DGKZ CPT1A ATP9A SHANK3 SART1 MACF1 CTNND1 TNR	1.73e-07	430	292	17	32581705
Pubmed	The functional interactome landscape of the human histone deacetylase family.	ZNF609 ING2 ETV6 ACTL6A GSE1 SYNE2 CPNE3 GCN1 IPO5 ATG2B CCT4 CPT1A P4HA1 ATP2A3	1.91e-07	289	292	14	23752268
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	USP34 SPTBN2 PHB2 ACTL6A NCBP3 CSDE1 LONP1 DDX46 AP2B1 SYNE2 ASCC2 QARS1 GCN1 AP3D1 IPO5 FLOT2 AKT3 CCDC22 GNL3L CALD1 PDCD6 ANXA5 UBR4 TRIOBP LAMB1 CCT4 LBR NBAS THADA ATAD1 MDC1 ATM IPO11	2.05e-07	1440	292	33	30833792
Pubmed	Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.	DIS3L AP2B1 ASCC2 PLEKHA5 GCN1 TOP3B CCDC14 GPRIN3 TBC1D31 CCNB2 CTNND1	2.16e-07	169	292	11	31462741
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 EPPK1 ACACA OBSCN FYCO1 TRRAP BIRC6 LYST TBC1D16 PKD1 GCN1 TOP3B D2HGDH AP3D1 UBR4 NSD1 GRID1 WDR59 CCDC142 THADA CELSR2 SLC25A39 LRRC14 WDFY3 ARRDC2 ATP2A3 CYB5R2 ARHGAP33	2.53e-07	1105	292	28	35748872
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	ZNF609 PDE8A IFT172 GARS1 PHB2 SETDB1 LONP1 KIF3B AP2B1 COPS8 HPRT1 PLCL2 CPNE3 PLEKHA5 QARS1 GCN1 CCHCR1 ANK3 DYNC2H1 ANXA5 COBLL1 ATG2B CILK1 XIAP URGCP SART1 THADA ATAD1 PRKAR1A MAP3K21 IPO11	2.96e-07	1321	292	31	27173435
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	POP4 EPPK1 ACACA MYO6 RASSF2 ACTL6A CSDE1 QARS1 GCN1 IPO5 MINK1 UBR4 CCT4 PRKAR1A CTNND1 IPO11	3.31e-07	399	292	16	37536630
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ACACA RASSF2 EXPH5 DAPK2 PAK6 LYST TMCC3 ANLN SYNE2 PLEKHA5 FLOT2 RANBP3 COBLL1 MINK1 PAK5 XIAP LBR KIAA1191 WDR59 FAM13A ELMO2 MACF1 CTNND1 MAP3K21	3.55e-07	861	292	24	36931259
Pubmed	The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA.	USP34 MYO6 SLFN5 SETDB1 LONP1 DDX46 SIMC1 GCN1 AP3D1 IPO5 ARMCX3 CHTF18 ATM	3.99e-07	262	292	13	36880596
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	EPPK1 MYO6 BAX CSDE1 AP2B1 SYNE2 QARS1 AP3D1 CARM1 PDCD6 DYNC2H1 LAMB1 CELSR2 MDC1 MACF1	4.47e-07	358	292	15	32460013
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	ACTL6A LONP1 KIF3B CROCC2 TAF1L TARBP1 CCDC14 FLOT2 CALD1 UBR4 ACAD10 LBR SHANK3 URGCP THADA P4HA1 PRKAR1A DGKI LRRC14 IPO11 DNAH11	4.73e-07	689	292	21	36543142
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	MYO6 PHB2 CSDE1 PLEKHA5 QARS1 GCN1 AP3D1 CARM1 IPO5 FLOT2 CALD1 ANK3 COBLL1 MINK1 ATG2B PTPN23 CCT4 LBR MACF1 CTNND1 MAP3K21	7.32e-07	708	292	21	39231216
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 EPPK1 ACACA SPTBN2 TRRAP BIRC6 CSDE1 LONP1 DDX46 AP2B1 SYNE2 GCN1 IPO5 UBR4 NSD1 SART1 MDC1 RCL1 MACF1 ATM	8.27e-07	653	292	20	22586326
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 ZNF609 RIBC2 DIS3L ACTL6A DBT TRRAP SETDB1 GSE1 ASPM CHPF2 FLOT2 GNL3L IYD GPATCH2 KIAA1549 LAMB1 XIAP LBR SART1 YEATS2 THADA ATP2C1 P4HA1 MACF1 WDFY3 ARHGAP33	1.02e-06	1116	292	27	31753913
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	EPPK1 ACACA GARS1 PHB2 BIRC6 CSDE1 LONP1 DDX46 AP2B1 HPRT1 SYNE2 QARS1 GCN1 TARBP1 AP3D1 CARM1 IPO5 PDCD6 ANXA5 UBR4 PTPN23 CCT4 CPT1A ARMCX3 SART1 GTF2B CHTF18 MDC1 PRKAA1 MACF1 CTNND1	1.27e-06	1415	292	31	28515276
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	BAX ACTL6A TRRAP DDX46 ANLN CPNE1 TAF1L GCN1 IPO5 CCT4 ARMCX3 SART1 GTF2B INTS4 IPO11	1.30e-06	390	292	15	17643375
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	EPPK1 ACACA GARS1 PHB2 FYCO1 AP2B1 HPRT1 CPNE3 QARS1 GCN1 AP3D1 IPO5 ANK3 DYNC2H1 ANXA5 UBR4 GPRIN3 CCT4 CPT1A NBAS NT5C2 MACF1	1.59e-06	807	292	22	30575818
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 MYO6 DIS3L IFT172 SPTBN2 CSDE1 SETDB1 TTC7B AP2B1 SACS PKD1 QARS1 TARBP1 IPO5 ANK3 UBR4 APBA1 TRIOBP LAMB1 WDR59 TXNDC11 SPTBN4 FBH1 PRKAR1A MACF1 ATM WDFY3 FUT8 QTRT1	1.59e-06	1285	292	29	35914814
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	EPPK1 ACACA GARS1 TRRAP BIRC6 CSDE1 AP2B1 ANLN HPRT1 SYNE2 QARS1 TOP3B AP3D1 IPO5 FLOT2 PDCD6 UBR4 LAMB1 PTPN23 CCT4 LBR CPT1A SART1 P4HA1 MDC1 NT5C2 PRKAR1A MACF1 KDM2A	1.91e-06	1297	292	29	33545068
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	EPPK1 CSDE1 ANLN MYPN ASPM PLEKHA5 GCN1 AP3D1 RANBP3 ATG2B CCT4 CTNND1	2.02e-06	256	292	12	33397691
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	EPPK1 SPTBN2 TRRAP NCBP3 LONP1 DDX46 STXBP2 SACS HPRT1 SYNE2 CPNE3 QARS1 GCN1 IPO5 FLOT2 CALD1 ANXA5 CCT4 LBR SART1 MDC1 PRKAA1 PRKAR1A MACF1 CTNND1	2.21e-06	1024	292	25	24711643
Pubmed	Caspase-3/caspase-8, bax and bcl2 in pulps of human primary teeth with physiological root resorption.	BAX BCL2 CASP8	2.33e-06	4	292	3	21819468
Pubmed	Synergistic effects of valproic acid and arsenic trioxide on RPMI8226 cells in vitro and the possible underlying mechanisms.	BAX BCL2 CASP8	2.33e-06	4	292	3	25815518
Pubmed	Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway.	BAX BCL2 BIK	2.33e-06	4	292	3	12853473
Pubmed	Placental apoptotic markers are associated with placental morphometry.	BAX BCL2 CASP8	2.33e-06	4	292	3	34534910
Pubmed	Defining the membrane proteome of NK cells.	PIGN MYO6 BAX FYCO1 BIRC6 LONP1 KIF3B AP2B1 PLEKHA5 CHPF2 GCN1 AP3D1 IPO5 FLOT2 GNL3L ANXA5 UBR4 LBR CPT1A NBAS ATP2C1 ATAD1 P4HA1 CHTF18 PRKAR1A FUT8 IL1RAP	2.38e-06	1168	292	27	19946888
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	EPPK1 ACACA MYO6 PHB2 TRRAP BIRC6 STXBP2 ANLN HPRT1 CPNE3 GCN1 AP3D1 CARM1 MRI1 UBR4 SAE1 PTPN23 CCT4 NBAS ATP2A3	2.59e-06	704	292	20	29955894
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SLFN5 CYP46A1 DDX46 GSE1 PLEKHA5 SDK2 ANK3 UBR4 LBR SPTBN4 SART1 MDC1 MACF1 MAP3K21	2.68e-06	361	292	14	26167880
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 ZNF609 MTSS1 DDX46 ACSBG1 HECW2 CPNE1 PLEKHA5 DAGLA PLXNB1 SDK2 ZNF507 TRIOBP KIAA1549 URGCP RBM12 MDC1	2.96e-06	529	292	17	14621295
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ZNF609 ACACA BAX BCL2 TRRAP BIRC6 TBC1D20 SEMA4C DDX46 SERPINB3 ASPM GCN1 CARM1 IPO5 MRM2 RANBP3 UBR4 WDR59 NBAS ATP2C1 ATAD1 ELMO2 SLC25A39 NR5A2 NT5C2 PRKAR1A KDM2A CPEB1 ABHD11	2.98e-06	1327	292	29	32694731
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ACACA SEMA4C TTC7B PLEKHA5 SLC12A6 FLOT2 ANK3 MINK1 TRIOBP GPRIN3 CELSR2 ELMO2 MACF1 CTNND1 SNTB1	3.32e-06	421	292	15	36976175
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	EPPK1 SH3BP1 ACTL6A CSDE1 LONP1 SERPINB3 GCN1 IPO5 FLOT2 CALD1 PDCD6 PLEKHG4 ANXA5 LBR WDR59 ARHGEF15 PLEKHG6 FAM13A ELMO2 RCL1 NT5C2 CTNND1 ARHGAP33	3.61e-06	916	292	23	32203420
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	PSG6 DAPK2 BAX SEMA4C BIK KIF3B AP2B1 HECW2 CPNE3 TAF1L CARM1 AKT3 GNL3L CALML3 NSD1 XIAP ATP2C1 PRKAR1A KDM2A DNAH11	4.45e-06	730	292	20	34857952
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SGSM1 ACACA SPTBN2 GARS1 OBSCN SLFN5 BIRC6 USP20 YOD1 GSE1 HECW2 VPS13A PKD1 CARM1 UBR4 PBX4 P4HA1 CHRD ATM TNR	5.02e-06	736	292	20	29676528
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	MYO6 PHB2 BAX SEMA4C CSDE1 CHPF2 QARS1 GCN1 TARBP1 GNL3L DYNC2H1 UBR4 LBR CPT1A ATP9A URGCP THADA ATP2C1 ATAD1 P4HA1 CCNB2 FUT8 IPO11	5.70e-06	942	292	23	31073040
Pubmed	Silver nanoparticles biosynthesized using Achillea biebersteinii flower extract: apoptosis induction in MCF-7 cells via caspase activation and regulation of Bax and Bcl-2 gene expression.	BAX BCL2 CASP8	5.79e-06	5	292	3	25665064
Pubmed	Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.	BAX BCL2 CASP8	5.79e-06	5	292	3	19621384
Pubmed	Impaired kinetics of Bax-GFP and Smac/DIABLO-GFP in caspase-8- and bid-silenced and Bcl-2 overexpressed breast cancer MCF-7 cells exposed to camptothecin.	BAX BCL2 CASP8	5.79e-06	5	292	3	17666167
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	USP34 PHB2 ETV6 RABGAP1 TRRAP CSDE1 LONP1 DDX46 CPNE3 CPNE1 CARM1 IPO5 ANXA5 UBR4 SAE1 CCT4 SART1 GTF2B RBM12 CHTF18 MDC1 KDM2A ATM CTNND1	5.99e-06	1014	292	24	32416067
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	PDE8A FYCO1 RABGAP1 LYST SEMA4C SYNE2 VPS13A SLC12A6 FLOT2 ATG2B LBR ATP9A ARMCX3 WDR59 NBAS CTNND1	6.76e-06	504	292	16	34432599
Pubmed	Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.	MTSS1 ETV6 SGCZ ANO2 LAMB1 LBP LBR TEK MDC1 FUT8	7.90e-06	199	292	10	23382691
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	EPPK1 MYO6 SPTBN2 GARS1 PHB2 AP2B1 CPNE1 QARS1 FLOT2 CALD1 PDCD6 ANPEP ANXA5 CCT4 LBR CPT1A CTNND1	9.90e-06	580	292	17	35676659
Pubmed	Altered apoptosis of inflammatory neutrophils in MMP-9-deficient mice is due to lower expression and activity of caspase-3.	BAX BCL2 CASP8	1.15e-05	6	292	3	19682497
Pubmed	BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins.	BAX BCL2 CASP8	1.15e-05	6	292	3	10716992
Pubmed	The mechanism of neogambogic acid-induced apoptosis in human MCF-7 cells.	BAX BCL2 CASP8	1.15e-05	6	292	3	21785112
Pubmed	Cell death in development.	BAX BCL2 CASP8	1.15e-05	6	292	3	9988219
Pubmed	In vivo assembly of the axon initial segment in motor neurons.	SPTBN2 ANK3 SPTBN4	1.15e-05	6	292	3	23728480
Pubmed	Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase theta facilitates induction of CYP17.	CYP17A1 DGKZ NR5A2	1.15e-05	6	292	3	17664281
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ACACA MYO6 GARS1 PHB2 ACTL6A DBT JARID2 LONP1 SERPINB3 HPRT1 QARS1 GCN1 IPO5 FLOT2 GNL3L DYNC2H1 ANXA5 UBR4 XIAP CCT4 LBR GRM1 SART1 THADA MDC1 RCL1 PRKAR1A ATM CTNND1	1.15e-05	1425	292	29	30948266
Pubmed	Functional proteomics mapping of a human signaling pathway.	MYO6 EXPH5 SETDB1 KIF3B ANTXR2 PLCL2 PKD1 ASCC2 QARS1 MRI1 ANK3 UBR4 CILK1 PRKAR1A MACF1 KDM2A IL1RAP	1.26e-05	591	292	17	15231748
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	USP34 PHB2 SEMA4C CSDE1 VPS13A SLC12A6 CALD1 PLEKHG4 DYNC2H1 ANXA5 ACAD10 ADGRG6 THADA CELSR2 DTWD2 ELMO2 NR5A2 INTS4 MACF1 ATM WDFY3 FUT8 ATP2A3 IPO11	1.26e-05	1061	292	24	33845483
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	GABRG2 SPTBN2 GARS1 PHB2 TKTL1 LYST ANTXR2 STXBP2 AP2B1 SACS FAM186A SYNE2 VPS13A ASPM TOP3B AP3D1 SLC12A6 CALD1 ZSWIM5 UBR4 REL CCT4 SPTBN4 SART1 TBC1D31 PCDHGA12 MACF1 ATM ATP2A3	1.44e-05	1442	292	29	35575683
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	MYO6 EXPH5 PLEKHA5 GCN1 AP3D1 ANK3 KIAA1549 LBR TBC1D31 MACF1 CTNND1	1.58e-05	263	292	11	34702444
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	EPPK1 ACACA MYO6 SPTBN2 GARS1 BAX ACTL6A DDX46 STXBP2 AP2B1 COPS8 HPRT1 QARS1 GCN1 AP3D1 IPO5 CALD1 ANK3 ANXA5 UBR4 SAE1 CCT4 P4HA1 PRKAR1A MACF1	1.59e-05	1149	292	25	35446349
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	USP34 ZNF609 BIRC6 SETDB1 COPS8 ANLN PLEKHA5 FLOT2 CCDC22 GNL3L KIAA1191 WDR59 YEATS2 NBAS TBC1D31 ATAD1 P4HA1 MDC1 CTNND1	1.67e-05	733	292	19	34672954
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	USP34 ACACA GARS1 RABGAP1 BIRC6 CSDE1 AP2B1 COPS8 HPRT1 QARS1 GCN1 AP3D1 CARM1 IPO5 PRUNE2 CALD1 PDCD6 RANBP3 UBR4 SAE1 LAMB1 PTPN23 CCT4 ARMCX3 RBM12 NT5C2 PRKAR1A MACF1 IPO11	1.70e-05	1455	292	29	22863883
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	EPPK1 GARS1 PHB2 CSDE1 LONP1 DDX46 STXBP2 AP2B1 QARS1 GCN1 CARM1 IPO5 MRI1 LBR SART1 RBM12 CTNND1	1.77e-05	607	292	17	39147351
Pubmed	Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.	ACACA PHB2 AP2B1 ANLN SERPINB3 CPNE1 QARS1 GCN1 AP3D1 CALD1 CALML3 TRIOBP CCT4 MACF1 CTNND1	1.91e-05	488	292	15	31324722
Pubmed	The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.	BAX BCL2 BIK	2.00e-05	7	292	3	9463381
Pubmed	Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death.	BAX BIK CASP8	2.00e-05	7	292	3	9027312
Pubmed	Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1.	BAX BCL2 XIAP	2.00e-05	7	292	3	21768356
Pubmed	harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L).	BAX BCL2 BIK	2.00e-05	7	292	3	9130713
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	SPTBN2 GARS1 CROCC2 MROH7 PRUNE2 CACNA1B PDCD6 ANPEP CALML3 MROH2A LAMB1 AGO1 NR5A2 PRKAR1A MACF1	2.31e-05	496	292	15	31343991
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	USP20 SYNE2 VPS13A COBLL1 CILK1 KDM2A WDFY3	2.56e-05	102	292	7	10231032
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	USP34 MYO6 PDK3 GARS1 PHB2 ACTL6A DBT TRRAP CSDE1 LONP1 AP2B1 COPS8 HPRT1 SIMC1 CPNE3 ASCC2 QARS1 CARM1 IPO5 CCT4 LBR LMOD2 ARMCX3 TTLL11 RCL1 PRKAR1A CTNND1	2.61e-05	1335	292	27	29229926
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	FBXO40 BIRC6 TMCC3 PAK5 GRID1 YEATS2 MACF1	2.73e-05	103	292	7	10574462
Pubmed	Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens.	RASSF2 NCF4 CPNE3 CPNE1 UBR4 P4HA1 NT5C2 MACF1	2.99e-05	143	292	8	30397336
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	USP34 ZNF609 ETV6 SLFN5 LONP1 GCN1 IPO5 UBR4 PRKAR1A MACF1 CTNND1	3.00e-05	282	292	11	23667531
Pubmed	[Morphological, cytogenetic and molecular biological characteristics of lung cancer in persons exposed for a long time to radionuclide radiation pollution in the Semipalatinsk region of Kazakhstan].	BAX BCL2 IGFBP2	3.18e-05	8	292	3	12575534
Pubmed	Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor.	BCL2 KHDC1L CASP8	3.18e-05	8	292	3	14657025
Pubmed	The membrane-associated inhibitor of apoptosis protein, BRUCE/Apollon, antagonizes both the precursor and mature forms of Smac and caspase-9.	BIRC6 CASP8 XIAP	3.18e-05	8	292	3	15507451
Pubmed	Human transcription factor protein interaction networks.	ZNF609 MYO6 ING2 DIS3L PHB2 ETV6 ACTL6A DBT TRRAP SETDB1 LONP1 GSE1 SYNE2 QARS1 TAF1L FLOT2 UBR4 ZNF507 REL CCT4 LBR YEATS2 RBM12 AGO1 MDC1 NT5C2 SNTB1 CPEB1	3.22e-05	1429	292	28	35140242
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	PIGN USP34 RABGAP1 CSDE1 COPS8 TXNDC16 PLEKHA5 CHPF2 PLXNB1 CALD1 ANPEP KIAA1549 LAMB1 LBR CPT1A ATP9A TXNDC11 GAL THADA CELSR2 P4HA1 ATM FUT8 IL1RAP ATP2A3	3.30e-05	1201	292	25	35696571
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	PHB2 FYCO1 TXNDC16 CHPF2 GCN1 CARM1 CCDC22 ARMCX3 TXNDC11 ATP2A3 IPO11	3.30e-05	285	292	11	32838362
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	USP34 RASSF2 TRRAP LYST AP2B1 ANLN TAF1L SLC25A23 CARM1 CALD1 MINK1 PAK5 GPATCH2 ACAD10 AGO1 CCNB2 PRKAA1 PRKAR1A CTNND1 MAP3K21 SNTB1	3.34e-05	910	292	21	36736316
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	TRRAP NCBP3 DDX46 GSE1 AP3D1 PDCD6 RANBP3 UBR4 SART1 MDC1 KDM2A IPO11	3.60e-05	341	292	12	32971831
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP34 ACACA MYO6 BAX BIRC6 SEMA4C VPS13A GCN1 AP3D1 ANK3 MINK1 GPRIN3 CCT4 LBR ARMCX3 SART1 THADA DTWD2 CTNND1	3.69e-05	777	292	19	35844135
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	MYO6 SPTBN2 PHB2 RABGAP1 ACTL6A CSDE1 AP2B1 CPNE3 QARS1 AP3D1 FLOT2 CCDC22 GNL3L CALD1 SAE1 DGKZ CCT4 SART1 PRKAR1A MACF1	3.75e-05	847	292	20	35235311
Pubmed	POU-domain factor Brn3a regulates both distinct and common programs of gene expression in the spinal and trigeminal sensory ganglia.	SST ANTXR2 GAL LIX1	3.80e-05	23	292	4	17239249
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	EPPK1 ACACA GARS1 BAX RABGAP1 ACTL6A CSDE1 SETDB1 DDX46 ANLN SERPINB3 SYNE2 CPNE1 QARS1 GCN1 CALD1 CALML3 RANBP3 UBR4 PTPN23 CCT4 ATAD1 P4HA1 CHTF18 PRKAA1 RCL1 IPO11	3.91e-05	1367	292	27	32687490
Pubmed	Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.	PDE8A PKD1 IPO5 FLOT2 PDCD6 CCT4 P4HA1 ATP2A3 IPO11	4.38e-05	195	292	9	17110338
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	GABRG2 PAK6 SCN1A SDK2 ANK3 GRID1 SHANK3 P4HA1 MACF1	4.74e-05	197	292	9	36604605
Pubmed	Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.	BAX BCL2 PKD1	4.74e-05	9	292	3	15761494
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	MYO6 DBT TRRAP USP20 YOD1 LONP1 AP2B1 COPS8 CPNE3 CPNE1 GCN1 TARBP1 CCDC14 IPO5 DYNC2H1 CALML3 XIAP WDR59 SART1 ATAD1 LRRC14 CTNND1	4.76e-05	1005	292	22	19615732
Interaction	FBXO22 interactions	ACACA MYO6 EXPH5 SPTBN2 OBSCN ACTL6A TRRAP NCBP3 DDX46 COPS8 CROCC2 KIF19 ASCC2 PLEKHA5 QARS1 TOP3B AP3D1 GNL3L ANK3 KMO SART1 P4HA1 ATM CTNND1 ATP2A3 IPO11	7.39e-08	540	288	26	int:FBXO22
Interaction	BSG interactions	GARS1 SLFN5 PAK6 TRRAP LONP1 AP2B1 ANLN HPRT1 GCN1 TARBP1 IPO5 SLC12A6 FLOT2 GNL3L ANPEP RANBP3 SAE1 GPRIN3 ACAD10 SPTBN4 ATAD1 P4HA1 ATM WDFY3 SNTB1 IPO11	1.45e-06	631	288	26	int:BSG
Interaction	SCN11A interactions	SCN1A SCN10A CACNA1A CACNA1B ATP2C1	1.54e-06	15	288	5	int:SCN11A
Interaction	SCN5A interactions	SCN1A SCN10A TOP3B CACNA1A CACNA1B ATP2C1 SNTB1	4.36e-06	47	288	7	int:SCN5A
Interaction	RHOB interactions	EPPK1 MYO6 SPTBN2 SEMA4C LONP1 ANTXR2 TTC7B AP2B1 ANLN HPRT1 VPS13A PLEKHA5 SLC12A6 FLOT2 SDK2 GNL3L ANK3 MINK1 TRIOBP KIAA1549 GPRIN3 CCT4 ADGRG6 ATAD1 MACF1 CTNND1 MAP3K21 IL1RAP SNTB1	1.13e-05	840	288	29	int:RHOB
Interaction	SPHK2 interactions	BCL2 HECW2 TOP3B PRKAA1 PRKAR1A	2.42e-05	25	288	5	int:SPHK2
Interaction	LSM14B interactions	NCBP3 CSDE1 ANLN HECW2 TOP3B IPO5 CILK1 LBR CPEB1	2.68e-05	109	288	9	int:LSM14B
Interaction	PML interactions	USP34 ZNF609 POP4 ACACA MYO6 BCL2 SLFN5 CSDE1 SETDB1 LONP1 DDX46 ANLN SYNE2 SIMC1 GCN1 AP3D1 IPO5 CALD1 CALML3 PAK5 CASP8 XIAP ARMCX3 SART1 YEATS2 GTF2B RBM12 CHTF18 MDC1 ATM	3.05e-05	933	288	30	int:PML
Interaction	TNIK interactions	SPTBN2 LONP1 GSE1 AP2B1 SYNE2 PLEKHA5 CARM1 CACNA1A ANK3 MINK1 PAK5 SHANK3 SART1 DGKI MACF1 CTNND1 TNR	3.76e-05	381	288	17	int:TNIK
Interaction	CIT interactions	EPPK1 MYO6 DAPK2 SPTBN2 PHB2 ACTL6A TRRAP BIRC6 TYRP1 LONP1 DDX46 AP2B1 ANLN HECW2 SYNE2 QARS1 GCN1 TOP3B TARBP1 CARM1 IPO5 FLOT2 PDCD6 DYNC2H1 UBR4 CCT4 SHANK3 TXNDC11 SPTBN4 SART1 NBAS CELSR2 ATAD1 P4HA1 MDC1 RCL1 INTS4 MACF1 KDM2A CTNND1	4.73e-05	1450	288	40	int:CIT
Interaction	NPTN interactions	SERPINB3 SIMC1 GCN1 D2HGDH TARBP1 PLEKHG4 DYNC2H1 ACAD10 CPT1A TXNDC11 THADA P4HA1 ATM IPO11	5.05e-05	278	288	14	int:NPTN
Interaction	SCN1A interactions	SCN1A SCN10A CACNA1A CACNA1B ANK3	5.16e-05	29	288	5	int:SCN1A
Interaction	KCNA3 interactions	EPPK1 MYO6 EXPH5 PHB2 BAX FYCO1 CSDE1 VPS13A PLEKHA5 QARS1 GCN1 AP3D1 CARM1 IPO5 CACNA1B FLOT2 CALD1 ANK3 COBLL1 MINK1 ATG2B PTPN23 CCT4 LBR YEATS2 MACF1 CTNND1 MAP3K21	5.70e-05	871	288	28	int:KCNA3
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	SPTBN2 ANLN PLEKHA5 AKT3 PLEKHG4 TRIOBP SPTBN4 PLEKHG6 SNTB1	3.25e-04	206	189	9	682
GeneFamily	ATPase phospholipid transporting	ATP9B ATP9A ATP10D	4.66e-04	15	189	3	1210
Coexpression	ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN	USP34 ZNF609 DIS3L TTC39C PHB2 BCL2 TKTL1 NIBAN3 USP20 SEMA4C PIK3IP1 CSDE1 FCRL1 SACS VNN1 VPS13A SLC25A23 TARBP1 IPO5 AKT3 PLXDC1 COBLL1 ZNF507 FCRL6 TBC1D31 RCL1 MACF1 ATM MYBL1	3.15e-06	1012	290	29	M40864
Coexpression	HUTTMANN_B_CLL_POOR_SURVIVAL_DN	PDE8A MTSS1 AKT3 COBLL1 ATP10D FUT8 MYBL1	3.94e-06	59	290	7	M12653
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	USP34 ZNF609 RASSF2 TTC39C SH3BP1 BCL2 SLFN5 BIRC6 LYST USP20 TBC1D20 PIK3IP1 CSDE1 JARID2 ANTXR2 MS4A2 SACS TBCC FLOT2 PLXDC1 UBR4 NSD1 CASP8 XIAP GPRIN3 CCT4 LBR FCRL6 RBM12 CSF1 ELMO2 PRKAR1A MACF1 KDM2A ATM MYBL1	9.65e-06	1492	290	36	M40023
Coexpression	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	ZNF609 DAPK2 CARM1 IPO5 ANPEP NSD1 SAE1 GAL CELSR2 RCL1 LRRC14	1.47e-05	199	290	11	M7259
Coexpression	GSE10325_CD4_TCELL_VS_MYELOID_UP	BCL2 TKTL1 USP20 PIK3IP1 SYNE2 AKT3 ANK3 PLXDC1 SAE1 CCT4 MYBL1	1.47e-05	199	290	11	M3078
Coexpression	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP	ZNF609 DAPK2 SPTBN2 CARM1 IPO5 ANPEP PLXDC1 NSD1 SAE1 CPT1A LRRC14	1.54e-05	200	290	11	M7256
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	RASSF2 TRRAP DDX46 CPNE3 ASPM GCN1 AP3D1 IPO5 AKT3 LBR MACF1 FUT8	2.47e-05	250	290	12	M11318
Coexpression	GOZGIT_ESR1_TARGETS_DN	MYO6 PSG6 PDK3 SPTBN2 MTSS1 PRRT3 PLEKHA5 CLNK SLC12A6 SDK2 ANK3 COBLL1 GPATCH2 REL CPT1A ATP9A ARMCX3 CELSR2 NR5A2 PRKAR1A MACF1 FUT8 ATP2A3	2.48e-05	786	290	23	M10961
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	PDE8A BCL2 SYNE2 VPS13A PLEKHA5 PRUNE2 CALD1 ANK3 GPC6 WDFY3	2.84e-05	176	290	10	M39223
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL	SPTBN2 BCL2 SST USP20 BIK KIF19 PRUNE2 CACNA1A AKT3 DGKZ GPC6 CHRD ATP2A3	3.81e-05	304	290	13	M45711
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	PDE8A MYO6 BCL2 SYNE2 VPS13A PLEKHA5 PRUNE2 CALD1 ANK3 GPC6 WDFY3	3.87e-05	221	290	11	M39222
Coexpression	LU_AGING_BRAIN_UP	RASSF2 MTSS1 BCL2 ACTL6A ACSBG1 CPNE3 PLXNB1 CALD1 ANXA5 RGN RGS20 NT5C2	4.05e-05	263	290	12	M5547
Coexpression	GALI_TP53_TARGETS_APOPTOTIC_UP	BAX CASP8 ATM	7.20e-05	8	290	3	M16490
Coexpression	NUYTTEN_NIPP1_TARGETS_DN	EXPH5 BIK ANTXR2 AP2B1 ANLN HPRT1 SYNE2 PLCL2 PRRT3 IPO5 SLC12A6 ANPEP CILK1 XIAP LBR CPT1A ADGRG6 RBM12 SLC25A39 PRKAR1A LRRC14 ATP2A3 CDH11	7.46e-05	845	290	23	M18090
Coexpression	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	ZNF609 BAX ATP9B RABGAP1 DBT AP3D1 CALD1 CASP8 CILK1 FAM13A P4HA1 ATP2A3	7.65e-05	281	290	12	M7089
Coexpression	NUYTTEN_EZH2_TARGETS_DN	POP4 RIBC2 DIS3L RASSF2 PAK6 AP2B1 HPRT1 SYNE2 PRRT3 ASPM CCDC14 IPO5 SAE1 CCT4 LBR ADGRG6 THADA ATP2C1 RBM12 TBC1D31 CCNB2 CHTF18 MDC1 IL1RAP ABHD11 MYBL1	7.81e-05	1023	290	26	M17122
Coexpression	GSE17721_CTRL_VS_CPG_2H_BMDC_DN	JARID2 GJA4 CILP2 SCN1A SIMC1 CACNA1A CACNA1B PTPN23 GRID1 KMO	8.35e-05	200	290	10	M3760
ToppCell	normal_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	OBSCN GJA4 ANLN SYNE2 CALD1 PLXDC1 OLFML2B COBLL1 LAMB1 ADGRG6 RGN IGFBP2	1.46e-09	170	292	12	d69c0ea4cb6b204f19d0a5d2164afb42184779ac
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO6 MTSS1 SLFN5 LYST BIK SACS SYNE2 NSD1 TEK ARHGEF15 CDH11 IPO11	4.07e-09	186	292	12	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	normal_Lung-Fibroblasts-Pericytes\|normal_Lung / Location, Cell class and cell subclass	OBSCN GJA4 CLEC11A CALD1 PLXDC1 SGCA OLFML2B LAMB1 ADGRG6 RGN CHRD	3.37e-08	181	292	11	f74941e49950027360d71ea3b205fc20c6929766
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	USP34 TTC39C SYNE2 VPS13A AKT3 ANK3 PBX4 GPRIN3 MACF1 ATM FUT8	3.37e-08	181	292	11	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLFN5 F8 SEMA4C GJA4 HECW2 OLFML2B TEK PPEF1 ARHGEF15 CSF1 SNTB1	3.57e-08	182	292	11	f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 BCL2 SYNE2 VPS13A AKT3 ANK3 CASP8 GPRIN3 MACF1 ATM MYBL1	8.02e-08	197	292	11	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SEMA4C SYNE2 VPS13A AKT3 ANK3 PLXDC1 ZNF507 CASP8 GPRIN3 ATM MYBL1	8.02e-08	197	292	11	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	DAPK2 ANLN CLEC11A VPS13A CPNE3 ASPM CACNA1A THADA ATP2C1 CHTF18 FUT8	9.35e-08	200	292	11	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	GABRG2 HECW2 PKD1 PLEKHA5 TARBP1 CACNA1A CACNA1B ANK3 PAK5 SPTBN4 DGKI	9.35e-08	200	292	11	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	distal-mesenchymal-Pericyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	OBSCN GJA4 CLEC11A CALD1 PLXDC1 OLFML2B LAMB1 ADGRG6 RGN IGFBP2 CHRD	9.35e-08	200	292	11	867935701fac71a3fe01578362da0676f959736c
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|368C / Donor, Lineage, Cell class and subclass (all cells)	ANLN GCN1 TMEM86A TARBP1 PRUNE2 APBA1 TBC1D31 CCNB2 CHTF18 ARHGAP33	3.12e-07	179	292	10	ec69e1dd897414033ba5b007aa82655a79adca6c
ToppCell	facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLB1 TMEM200B GJA4 PLXNB1 SGCA JPH2 GAL SUSD5 SNTB1 CYB5R2	3.29e-07	180	292	10	0059e5acade6c895fd629767bea1c15f40b0d1b0
ToppCell	facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLB1 TMEM200B GJA4 PLXNB1 SGCA JPH2 GAL SUSD5 SNTB1 CYB5R2	3.29e-07	180	292	10	dfb8412e1e06fa7349e66eea2ef27d9ea98b7893
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SGSM1 TMCC3 TBC1D20 HECW2 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 LRRC36	4.91e-07	188	292	10	789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCell	Control-B_intermediate-6\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RASSF2 DAPK2 SH3BP1 NCF4 KIF3B SACS MRM2 UBR4 CASP8 ATP2A3	5.15e-07	189	292	10	11cb9a16f1de8f60af2073ed7ea6d4f41c02f299
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MTSS1 TMCC3 TBC1D20 HECW2 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 LRRC36	5.41e-07	190	292	10	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EXPH5 MTSS1 KIF19 PLEKHA5 ANK3 DYNC2H1 POU2AF1 IGFBP2 DYNLT5 DNAH11	6.24e-07	193	292	10	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 TMCC3 HECW2 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 CTNND1 LRRC36	6.24e-07	193	292	10	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 TMCC3 HECW2 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 CTNND1 LRRC36	6.24e-07	193	292	10	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMCC3 HECW2 AKT3 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 MACF1 CTNND1	6.54e-07	194	292	10	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	18-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	GJA4 MYOZ1 CALD1 PLXDC1 SGCA OLFML2B JPH2 IGFBP2 SUSD5 LIX1	6.86e-07	195	292	10	e0ee7905499ee1a1ca7b1184e2713028cf156985
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTC39C BCL2 PIK3IP1 SYNE2 ANK3 PBX4 GPRIN3 FAM13A ELMO2 MYBL1	7.18e-07	196	292	10	e4c76e7ad68455e51fe93ce588bcec9383f8654b
ToppCell	Transverse-T_cell-Tfh\|T_cell / Region, Cell class and subclass	OBSCN ATP9B CLNK APBA1 NSD1 ADGRG6 RBM12 AGO1 CTNND1 IL1RAP	8.25e-07	199	292	10	33ffea12b8228e0b5bd8942531c3b21d24224725
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 SYNE2 VPS13A AKT3 ANK3 CASP8 GPRIN3 MACF1 ATM MYBL1	8.25e-07	199	292	10	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	medial-mesenchymal-Pericyte-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GJA4 CLEC11A CALD1 PLXDC1 OLFML2B LAMB1 ADGRG6 RGN IGFBP2 CHRD	8.64e-07	200	292	10	bbda454260016be92b539e220ecf7bcbbc6139e4
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN GJA4 CALD1 PLXDC1 SGCA JPH2 LAMB1 GRID1 ADGRG6 RGN	8.64e-07	200	292	10	12326cc6f0af24bacba9493dc79e7c7347db2f41
ToppCell	medial-mesenchymal-Pericyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GJA4 CLEC11A CALD1 PLXDC1 OLFML2B LAMB1 ADGRG6 RGN IGFBP2 CHRD	8.64e-07	200	292	10	f36d7cb6345daccebf76997f998e35d959b59452
ToppCell	Bronchial-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN GJA4 CALD1 PLXDC1 SGCA JPH2 LAMB1 GRID1 ADGRG6 RGN	8.64e-07	200	292	10	362706445edb33b313684efe50b1f44f5f816e67
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GJA4 CLEC11A CALD1 PLXDC1 SGCA OLFML2B LAMB1 ADGRG6 RGN CHRD	8.64e-07	200	292	10	f9bc22ff17bb1c751e6b05bca3f403836f33459a
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GJA4 CLEC11A CALD1 PLXDC1 SGCA OLFML2B LAMB1 ADGRG6 RGN CHRD	8.64e-07	200	292	10	0a7640db28c708003d5da2d19eb651f6fedfd710
ToppCell	distal-2-mesenchymal-Pericyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GJA4 CLEC11A CALD1 PLXDC1 OLFML2B LAMB1 ADGRG6 RGN IGFBP2 CHRD	8.64e-07	200	292	10	4ee0b2f56c2652435fa78bf6b3c90cea28df74e0
ToppCell	distal-mesenchymal-Pericyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GJA4 CLEC11A CALD1 PLXDC1 OLFML2B LAMB1 ADGRG6 RGN IGFBP2 CHRD	8.64e-07	200	292	10	fe31287cfb51d45643bdedbaa5efc03ed87263c6
ToppCell	medial-2-mesenchymal-Pericyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GJA4 CLEC11A CALD1 PLXDC1 OLFML2B LAMB1 ADGRG6 RGN IGFBP2 CHRD	8.64e-07	200	292	10	9820fb4f6efcdfc6de937ef2302a98b48426baa3
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	USP34 BCL2 SYNE2 ANK3 CASP8 PBX4 GPRIN3 MACF1 ATM	1.28e-06	162	292	9	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	COVID-19-APC-like-Transitioning_MDM\|COVID-19 / group, cell type (main and fine annotations)	FBXO40 SGCZ MYPN CLNK IYD GRM1 PPEF1 SPACA1	1.85e-06	126	292	8	9f94291b1db020cc0ebf9c8de4e01bd883295672
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2L OBSCN HHATL MYOZ1 SCN10A SLC25A23 LMOD2 CHRD DGKI	1.91e-06	170	292	9	cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNPO2L OBSCN HHATL MYOZ1 SCN10A SLC25A23 LMOD2 CHRD DGKI	1.91e-06	170	292	9	da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXL13 LRRC74A SEMA4C TBC1D16 SYNE2 TMEM86A PLXDC1 CALML3 KMO	2.11e-06	172	292	9	30916a902c151907745756d14327e24adc34afef
ToppCell	3'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBXL13 SYNPO2L GJA4 MYOZ1 CACNA1A CALD1 SGCA RGN CSF1	2.55e-06	176	292	9	56e19240f4a7b617a986e3c0854b757394e78251
ToppCell	3'-Adult-LymphNode-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBXL13 SYNPO2L GJA4 MYOZ1 CACNA1A CALD1 SGCA RGN CSF1	2.55e-06	176	292	9	c88b46fe29ae7606c8880a6ff0ebb85c0dfda8bd
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NCF4 NIBAN3 FCRL1 COBLL1 IYD POU2AF1 LMOD2 RGN FCRL4	2.79e-06	178	292	9	be1d991c5a0a5be22f14f57d34ee1330f1a12963
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE8A ANLN SYNE2 CPNE3 ASPM FLOT2 OLFML2B LBP CCNB2	2.79e-06	178	292	9	15a99080e9f669572ab6d82934f324e6714846c1
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE8A ANLN SYNE2 CPNE3 ASPM FLOT2 OLFML2B LBP CCNB2	2.79e-06	178	292	9	200308e109abb7e6f8816a6f8cce6d56862d4098
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GJA4 ANO2 COBLL1 GPRIN3 TEK SHANK3 ARHGEF15 DGKI ATP2A3	2.79e-06	178	292	9	c227da59dc7beb73f84405bf13356bdeb59d9338
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6\|TCGA-Ovary / Sample_Type by Project: Shred V9	ANTXR2 CALD1 PLXDC1 OLFML2B JPH2 LAMB1 PCDHGA12 CHRD CDH11	2.79e-06	178	292	9	142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OBSCN SDK2 CALD1 DYNC2H1 LAMB1 GRID1 LBP CDH11 SNTB1	2.92e-06	179	292	9	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO6 MTSS1 SLFN5 SACS SYNE2 RPS6KL1 TEK ARHGEF15 NR5A2	3.20e-06	181	292	9	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	NS-critical-d_0-4-Lymphoid-Treg\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TTC39C SYNE2 CCDC14 ZNF507 CASP8 GPRIN3 TBC1D31 ATM MYBL1	3.50e-06	183	292	9	f478dfa231fc1b12ead0183cc9d22077cdf43d1f
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DAPK2 ANLN CLEC11A VPS13A CPNE3 ASPM CACNA1A CHTF18 FUT8	3.66e-06	184	292	9	081d045f3bc98a36f342de7d50f39c9a888dd7eb
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DAPK2 ANLN CLEC11A VPS13A CPNE3 ASPM CACNA1A CHTF18 FUT8	3.66e-06	184	292	9	84c20730cd92b9aaa50077d7b625e37e7f9e91d2
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	GJA4 ANO2 COBLL1 GPRIN3 TEK SHANK3 ARHGEF15 DGKI ATP2A3	3.66e-06	184	292	9	a809b0fa52df8a159f60f87eefcef61220af5e34
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DAPK2 ANLN CLEC11A VPS13A CPNE3 ASPM CACNA1A CHTF18 FUT8	3.66e-06	184	292	9	d31d4116d1d196633784863781fa45673607a421
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DAPK2 ANLN CLEC11A VPS13A CPNE3 ASPM CACNA1A CHTF18 FUT8	3.66e-06	184	292	9	a8c6028d745aaa6ee7842259238694cb50ce0526
ToppCell	Control-Myeloid_G-immature_Neutrophil\|Control / Disease group, lineage and cell class	DAPK2 ANLN CLEC11A VPS13A CPNE3 ASPM CACNA1A CHTF18 FUT8	3.66e-06	184	292	9	45f873236f7e90fb78c8e291d3b5b92d121acec9
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CALD1 PLXDC1 ZSWIM5 APBA1 LAMB1 ADGRG6 RGS20 CDYL2 DYNLT5	3.66e-06	184	292	9	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis	RASSF2 TMCC3 ANTXR2 CALD1 ANPEP OLFML2B LAMB1 CSF1 CDH11	4.00e-06	186	292	9	e93415b59dd89bc8a966dab0e0b65fe215933598
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIK ANLN ASPM COBLL1 POU2AF1 TXNDC11 GAL CCNB2 FUT8	4.18e-06	187	292	9	88d20f150df61ef0e3ee0c3e9895b094920c4b09
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	TTC39C BCL2 SYNE2 PLCL2 CASP8 PBX4 GPRIN3 ATM MYBL1	4.18e-06	187	292	9	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIK ANLN ASPM COBLL1 POU2AF1 TXNDC11 GAL CCNB2 FUT8	4.18e-06	187	292	9	158c2c003fd225ba61793fb06eece232fb063d05
ToppCell	facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MTSS1 FCRL1 TXNDC16 SLC12A6 POU2AF1 REL KMO MACF1 ATP2A3	4.18e-06	187	292	9	b51af2824e65734f333b1325117f4a2e88b17c23
ToppCell	facs-Spleen-nan-3m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MTSS1 FCRL1 TXNDC16 SLC12A6 POU2AF1 REL KMO MACF1 ATP2A3	4.18e-06	187	292	9	3ca3954f45f167e98a230f2847f0582d74fcd32e
ToppCell	PCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RASSF2 GJA4 ANO2 COBLL1 SHANK3 ARHGEF15 NR5A2 DYNLT5 TNR	4.18e-06	187	292	9	106f50ad85a92403037214f0e94702230284837f
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RASSF2 GJA4 ANO2 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 DGKI	4.36e-06	188	292	9	b66f1f08827dd6c48583d871f9f33ea41e48bfb2
ToppCell	15-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	MYOZ1 CALD1 PLXDC1 SGCA OLFML2B LAMB1 IGFBP2 SUSD5 LIX1	4.36e-06	188	292	9	4963382e54aac06bf5047c7d725393db70667ee7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO6 SPTBN2 MTSS1 CLNK COBLL1 ATP9A CDYL2 DGKI SNTB1	4.36e-06	188	292	9	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	facs-Heart-LA/RA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO2L OBSCN EXTL1 HHATL CILP2 MYPN ANK3 SGCA LMOD2	4.56e-06	189	292	9	a08b2d0fa35ffa510050ecffdc68e1b79bbe1632
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO40 SYNPO2L EXTL1 HHATL CILP2 MYPN SGCA GRM1 LMOD2	4.56e-06	189	292	9	b98f60875b1a12b2ec9dc91889298ae57f98602f
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SGSM1 TMCC3 HECW2 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 LRRC36	4.56e-06	189	292	9	e82211b9dc7540e7a183be2cbcfae39fdf503949
ToppCell	facs-Heart-LA/RA\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO2L OBSCN EXTL1 HHATL CILP2 MYPN ANK3 SGCA LMOD2	4.56e-06	189	292	9	efa913d9c16fc32166b484d92b6449e8a0c59e03
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO40 SYNPO2L EXTL1 HHATL CILP2 MYPN SGCA GRM1 LMOD2	4.56e-06	189	292	9	e758b264c0a47127e33e66c395cf5a3224c7305b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTC39C SLFN5 PIK3IP1 SYNE2 ANK3 GPRIN3 FAM13A ATM MYBL1	4.56e-06	189	292	9	5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169
ToppCell	Control-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MTSS1 TBC1D20 ANTXR2 HECW2 TEK ARHGEF15 IGFBP2 SNTB1 LRRC36	4.56e-06	189	292	9	5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BCL2 SLFN5 SYNE2 CASP8 GPRIN3 FCRL6 MACF1 ATM MYBL1	4.76e-06	190	292	9	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	human_hepatoblastoma-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	RASSF2 TMCC3 HECW2 ANO2 AKT3 JPH2 SHANK3 ARHGEF15 DGKI	4.76e-06	190	292	9	8d6ef93d69e96cd6921816d152bea3b0710cf147
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	RASSF2 GJA4 ANO2 GPRIN3 TEK SHANK3 ARHGEF15 NR5A2 DGKI	4.76e-06	190	292	9	7ba2be2630183df86de21689289a8620a4cd507e
ToppCell	Control-T_cells-CD4+_T_cells\|Control / group, cell type (main and fine annotations)	TTC39C BCL2 SYNE2 PLCL2 AKT3 CASP8 PBX4 GPRIN3 MYBL1	4.76e-06	190	292	9	0733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCell	COVID-19-Myeloid-DC1\|Myeloid / Condition, Lineage and Cell class	RIBC2 DAPK2 BIK CPNE3 PLEKHA5 CLNK FCRL6 ADGRG6 MYBL1	4.96e-06	191	292	9	4be3c6287965fe3a2f109d26f68bdc2fa393f99b
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 TMCC3 HECW2 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 LRRC36	5.18e-06	192	292	9	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	F8 GSE1 HECW2 ANO2 DGKZ TEK SHANK3 ARHGEF15 NR5A2	5.18e-06	192	292	9	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 TMCC3 HECW2 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 LRRC36	5.18e-06	192	292	9	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP34 ZNF609 PDE8A ETV6 ATP9B BIRC6 JARID2 DTWD2 DGKI	5.40e-06	193	292	9	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMCC3 ANTXR2 HECW2 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 LRRC36	5.40e-06	193	292	9	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RASSF2 GJA4 ANO2 TEK SHANK3 ARHGEF15 NR5A2 DYNLT5 TNR	5.40e-06	193	292	9	72d20ee257149b238016b44d183ce3fc24b8f621
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CILP2 OLFML2B GRID1 GPC6 TEK ARHGEF15 PCDHGA12 SUSD5 CHRD	5.40e-06	193	292	9	194e7fa00a50cc4e026987b715323d125d79594e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	F8 GSE1 HECW2 ANO2 DGKZ TEK SHANK3 ARHGEF15 NR5A2	5.40e-06	193	292	9	52e918884877b6659cdca0496390e440f73694a9
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 HECW2 AKT3 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 CTNND1	5.63e-06	194	292	9	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 HECW2 AKT3 TEK SHANK3 ARHGEF15 IGFBP2 NR5A2 CTNND1	5.63e-06	194	292	9	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTC39C BCL2 PIK3IP1 SYNE2 ANK3 GPRIN3 FAM13A ELMO2 ATM	5.63e-06	194	292	9	a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	GJA4 PRUNE2 CALD1 JPH2 LAMB1 GRID1 RGN IGFBP2 SUSD5	5.63e-06	194	292	9	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	356C-Endothelial_cells-Endothelial-A_(Artery)\|356C / Donor, Lineage, Cell class and subclass (all cells)	F8 ANO2 CALD1 LAMB1 TEK SHANK3 ARHGEF15 ADGRG6 NR5A2	5.63e-06	194	292	9	2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	CLEC11A PLXDC1 OLFML2B GPC6 TEK PCDHGA12 SUSD5 DYNLT5 CDH11	5.63e-06	194	292	9	2260cd817a6661e5eb6645b0c6786e18fd58371e
ToppCell	356C-Endothelial_cells-Endothelial-A_(Artery)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	F8 ANO2 CALD1 LAMB1 TEK SHANK3 ARHGEF15 ADGRG6 NR5A2	5.63e-06	194	292	9	b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200
ToppCell	COVID-19_Moderate-multiplets\|COVID-19_Moderate / disease group, cell group and cell class	SYNE2 CLNK SH2D7 PLXNB1 APBA1 GPRIN3 ADGRG6 MACF1	5.84e-06	147	292	8	baf15c773d7751bc6f64d4974a22738626f2b3ff
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	OBSCN BCL2 SLFN5 PIK3IP1 SYNE2 ANK3 GPRIN3 MACF1 ATM	5.87e-06	195	292	9	4bdedd924564a260841a9153604026b57487c83d
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	F8 HECW2 SYNE2 ANO2 TEK SHANK3 ARHGEF15 NR5A2 DYNLT5	5.87e-06	195	292	9	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	COPD-Lymphoid-T\|COPD / Disease state, Lineage and Cell class	TTC39C DAPK2 FYCO1 BCL2 PIK3IP1 SYNE2 ANK3 CASP8 PBX4	6.12e-06	196	292	9	30e53b8050d2a041f855d0e39bbd8f923c64c489
ToppCell	Sepsis-Int-URO-Lymphocyte-B-Plasmablast\|Int-URO / Disease, condition lineage and cell class	BIK ASPM C2orf42 PLXDC1 COBLL1 POU2AF1 TXNDC11 CCNB2 FUT8	6.12e-06	196	292	9	e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	GJA4 STXBP2 MYOZ1 PRUNE2 CALD1 SGCA JPH2 IGFBP2 SUSD5	6.12e-06	196	292	9	541b1fcf509e362f6f48720046cb5378aaf7c591
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo\|GI_small-bowel / Manually curated celltypes from each tissue	MYO6 DAPK2 FCRL1 CLNK SLC12A6 TBC1D31 CSF1 SEC14L6 FCRL4	6.12e-06	196	292	9	a54ec174461944229c98a0b48b4822a556191ccb
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|GI_small-bowel / Manually curated celltypes from each tissue	MYO6 DAPK2 FCRL1 CLNK SLC12A6 TBC1D31 CSF1 SEC14L6 FCRL4	6.12e-06	196	292	9	84cab9390794fe50203834b745722bf11c208ebd
Drug	Cocaine	GABRG2 SPTBN2 SYNPO2L OBSCN BAX ATP9B NCF4 BCL2 PAK6 TBC1D20 SEMA4C BIK TYRP1 TTC7B AP2B1 HECW2 SCN10A PLEKHA5 SLC25A23 SERTAD1 CARM1 MRM2 CALD1 PDCD6 UBR4 ATG2B LAMB1 CASP8 REL GRM1 SHANK3 SART1 GAL RBM12 RGS20 IGFBP2 ATAD1 CATSPER2 ATM FUT8 QTRT1	9.45e-08	1314	289	41	ctd:D003042
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; HL60; HT_HG-U133A	EXPH5 CYP17A1 DBT PIK3IP1 CLEC11A SCN10A SLC25A23 ANK3 MINK1 NSD1 GRM1 CSF1 ARHGAP33	1.44e-06	196	289	13	3118_DN
Drug	V ms	BIRC6 ANLN SERPINB3 CPNE1 ACAD10 TEK RBM12	2.69e-06	49	289	7	CID005289556
Drug	echinocystic acid	BAX BCL2 CASP8 XIAP	3.05e-06	9	289	4	ctd:C022999
Drug	2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone	BAX BCL2 CASP8 XIAP	3.05e-06	9	289	4	ctd:C446520
Drug	NSC618487	IL36A DAPK2 BAX NCF4 BCL2 ACTL6A PAK6 BIK LONP1 AP2B1 CPNE3 DAGLA SLC12A6 CALML3 ANXA5 PAK5 CASP8 XIAP DGKZ GRM1 TEK RGN ATP2C1 CSF1 CCNB2 PRKAA1 PRKAR1A DGKI IFNE ATP2A3	3.19e-06	933	289	30	CID000005279
Drug	AC1L9HHR	PIGN PLB1 SPTBN2 BAX BCL2 F8 CPNE3 CPNE1 CALML3 ANXA5 CASP8 XIAP DGKZ SPTBN4 RBM12 PRKAR1A DGKI	3.20e-06	354	289	17	CID000445141
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; HL60; HT_HG-U133A	USP34 PDK3 RABGAP1 DBT COPS8 CCDC22 GNL3L MINK1 REL ELMO2 MACF1 ATM	7.13e-06	193	289	12	2366_DN
Drug	Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A	PIGN USP34 RABGAP1 DBT CLEC11A GNL3L RANBP3 MINK1 CASP8 REL ATM WDFY3	7.51e-06	194	289	12	3366_DN
Drug	hispanolone	BAX BCL2 CASP8 XIAP	7.82e-06	11	289	4	ctd:C501367
Drug	Porphyrins	BAX BCL2 ANPEP CASP8	7.82e-06	11	289	4	ctd:D011166
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; HL60; HG-U133A	CYP17A1 BAX LYST USP20 SEMA4C SETDB1 COPS8 CLEC11A AP3D1 CCDC22 MINK1 KDM2A	7.91e-06	195	289	12	1409_UP
Drug	STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A	BAX DBT SEMA4C AP2B1 DAGLA IPO5 MINK1 ACAD10 CELSR2 SLC25A44 KDM2A IL1RAP	7.91e-06	195	289	12	6561_UP
Drug	evoxanthine	BAX BCL2 ANXA5	8.02e-06	4	289	3	CID000348484
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A	DAPK2 USP20 MYOZ1 CLEC11A VPS13A CACNA1A SLC12A6 CALML3 RANBP3 COBLL1 MINK1 ATP2A3	8.34e-06	196	289	12	2232_DN
Drug	Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; HL60; HG-U133A	PIGN ACACA MTSS1 RABGAP1 CHPF2 AP3D1 IPO5 GPATCH2 URGCP SLC25A44 MACF1 KDM2A	9.24e-06	198	289	12	1583_DN
Drug	sanguinarine	BAX BCL2 ANPEP ANXA5 CASP8 ATP2C1 ATP2A3	1.07e-05	60	289	7	CID000005154
Drug	Aristolochic Acids	ACACA MYPN GRID1 LBP CPT1A ELMO2 CCNB2 ATM	1.77e-05	89	289	8	ctd:D034341
Drug	AC1L9K72	PIGN PLB1 SPTBN2 ATP9B LYST DAGLA ANO2 PLEKHG4 ANXA5 DGKZ CPT1A ATP9A SPTBN4 DGKI	2.24e-05	290	289	14	CID000446872
Drug	10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one	BAX BCL2 CASP8 XIAP	2.30e-05	14	289	4	ctd:C554291
Drug	cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A	MYO6 GARS1 NCF4 PIK3IP1 TBC1D16 LONP1 CLEC11A COBLL1 NBAS ELMO2 ATP2A3	3.33e-05	190	289	11	612_UP
Drug	Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; HL60; HT_HG-U133A	ZNF609 ATP9B DBT SEMA4C CCDC22 CILK1 ACAD10 CPT1A WDFY3 FUT8 SNTB1	3.84e-05	193	289	11	1341_UP
Drug	olaquindox	BAX BCL2 HPRT1	3.94e-05	6	289	3	ctd:C013168
Drug	thiosulfinic acids	BAX BCL2 CASP8	3.94e-05	6	289	3	ctd:C100040
Drug	Epothilones	BAX BCL2 XIAP	3.94e-05	6	289	3	ctd:D034261
Drug	AC1L4NYW	BAX ANXA5 CASP8	3.94e-05	6	289	3	CID000189051
Drug	grifolin	BAX BCL2 CASP8	3.94e-05	6	289	3	ctd:C058858
Drug	alborixin	BAX BCL2 CASP8	3.94e-05	6	289	3	ctd:C012708
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	RIBC2 DAPK2 USP20 VPS13A MINK1 CASP8 GRM1 ATP10D CATSPER2 MACF1 WDFY3	4.03e-05	194	289	11	5457_DN
Drug	Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	RIBC2 DAPK2 RABGAP1 PLXNB1 IPO5 GNL3L COBLL1 LAMB1 CSF1 LRRC14 ATM	4.22e-05	195	289	11	3525_DN
Drug	Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; PC3; HT_HG-U133A	USP34 CYP17A1 ATP9B RABGAP1 DBT SYNE2 VPS13A MINK1 LRRC14 QTRT1 IL1RAP	4.42e-05	196	289	11	7312_DN
Drug	Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; HL60; HT_HG-U133A	MYO6 MTSS1 ACSBG1 VNN1 DAGLA PRUNE2 CALD1 ANK3 APBA1 CTNND1 ARHGAP33	4.42e-05	196	289	11	2735_UP
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A	ZNF609 ATP9B DBT SEMA4C YOD1 SCN10A MINK1 CPT1A CELSR2 CTNND1 FUT8	4.42e-05	196	289	11	3121_DN
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	RIBC2 BAX AP2B1 SCN10A DAGLA AP3D1 IPO5 TRIOBP KMO SLC25A44 KDM2A	4.42e-05	196	289	11	6559_UP
Drug	Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A	PDK3 BAX BIK COPS8 VPS13A CILK1 ACAD10 URGCP CELSR2 WDFY3 IL1RAP	4.42e-05	196	289	11	6344_DN
Drug	Furazolidone [67-45-8]; Down 200; 17.8uM; HL60; HT_HG-U133A	PDK3 PIK3IP1 SCN10A CACNA1A ANK3 DYNC2H1 CILK1 CPT1A KMO FAM13A MYBL1	4.63e-05	197	289	11	3019_DN
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; HL60; HT_HG-U133A	PDE8A PIK3IP1 COPS8 AP3D1 CALD1 PLXDC1 RANBP3 GPATCH2 GRM1 SNTB1 MYBL1	4.63e-05	197	289	11	3006_DN
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	USP34 EPPK1 RABGAP1 LYST SEMA4C GNL3L DYNC2H1 COBLL1 TRIOBP CASP8 KDM2A	4.63e-05	197	289	11	4988_DN
Drug	Ganciclovir [82410-32-0]; Down 200; 15.6uM; PC3; HT_HG-U133A	EPPK1 MYO6 DBT TRRAP BIK SETDB1 RANBP3 REL THADA RBM12 ATM	4.63e-05	197	289	11	6289_DN
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A	ATP9B FYCO1 DBT CLEC11A PLXNB1 CCDC22 RANBP3 MACF1 KDM2A WDFY3 ATP2A3	4.85e-05	198	289	11	7323_DN
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A	GABRG2 ZNF609 MTSS1 BCL2 EXTL1 DAGLA PRUNE2 DYNC2H1 WDR59 CATSPER2 WDFY3	4.85e-05	198	289	11	5406_UP
Drug	Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; MCF7; HT_HG-U133A	BAX F8 NCBP3 SETDB1 STXBP2 PLXNB1 CCDC22 RANBP3 SLC25A44 KDM2A ATP2A3	4.85e-05	198	289	11	6261_DN
Drug	Furosemide	DAPK2 BAX BCL2 BIRC6 BIK SLC12A6 CASP8 XIAP TEK ATM	4.89e-05	164	289	10	ctd:D005665
Drug	Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A	LYST SCN10A PLXNB1 IPO5 SLC12A6 FLOT2 AKT3 CALML3 APBA1 QTRT1 IL1RAP	5.07e-05	199	289	11	5516_UP
Drug	Foliosidine [2520-38-9]; Up 200; 13uM; HL60; HT_HG-U133A	ATP9B BCL2 PIK3IP1 AKAP4 ACSBG1 MROH7 SLC25A23 CALD1 PAK5 GRM1 ATP2A3	5.07e-05	199	289	11	2201_UP
Drug	Skimmianine [83-95-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	FBXO40 DAPK2 SPTBN2 DBT DAGLA TOP3B PRUNE2 ANO2 MINK1 PAK5 SUSD5	5.07e-05	199	289	11	5766_UP
Drug	Ethamivan [304-84-7]; Down 200; 18uM; MCF7; HT_HG-U133A	RIBC2 EXPH5 DBT STXBP2 COPS8 SLC25A23 CCDC22 NSD1 CILK1 SLC25A44 QTRT1	5.07e-05	199	289	11	7021_DN
Drug	Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A	BAX RABGAP1 SETDB1 ACSBG1 CLEC11A PLCL2 CASP8 ACAD10 FAM13A SLC25A44 ARHGAP33	5.07e-05	199	289	11	7374_UP
Drug	cordycepin	BAX BCL2 CASP8 XIAP	5.31e-05	17	289	4	ctd:C058120
Drug	2-5,6,7,8,4'-pentamethoxyflavanone	BAX BCL2 CASP8	6.82e-05	7	289	3	ctd:C544133
Drug	methyl 5-chloro-4,5-didehydrojasmonate	BCL2 CASP8 XIAP	6.82e-05	7	289	3	ctd:C555027
Drug	fesiasept	BIK ANPEP IGFBP2	6.82e-05	7	289	3	CID000007563
Drug	hydroperoxyisophosphamide	BAX BCL2 CASP8	6.82e-05	7	289	3	ctd:C012353
Drug	plakin	SPTBN2 ACTL6A SYNE2 PLEKHG4 TXNDC11 SPTBN4 MACF1	8.33e-05	82	289	7	CID000018752
Drug	lonidamine	BAX BCL2 CASP8 XIAP	8.48e-05	19	289	4	ctd:C016371
Drug	bendamustine	BCL2 BIRC6 ANXA5 CASP8 XIAP	9.95e-05	37	289	5	CID000065628
Drug	AC1NS0KV	GABRG2 BAX BCL2 PKD1 TOP3B ANXA5 NSD1 CASP8 XIAP	1.02e-04	145	289	9	CID005326475
Drug	Viper Venoms	BAX BCL2 CASP8 XIAP	1.05e-04	20	289	4	ctd:D014757
Drug	demethoxyfumitremorgin C	BAX BCL2 CASP8	1.08e-04	8	289	3	ctd:C100698
Drug	codonoposide	BAX CASP8 XIAP	1.08e-04	8	289	3	ctd:C463759
Drug	paederosidic acid	BAX BCL2 CASP8	1.08e-04	8	289	3	ctd:C000588809
Drug	heliox	GARS1 CLNK CILK1	1.08e-04	8	289	3	CID000123812
Drug	clavulone I	BAX BCL2 CASP8	1.08e-04	8	289	3	CID005282264
Drug	Trypsin Inhibitors	BAX BCL2 CASP8	1.08e-04	8	289	3	ctd:D014361
Drug	nitrosocarbofuran	BAX ANXA5 CASP8	1.08e-04	8	289	3	CID000044098
Drug	caraway oil	BAX BCL2 CASP8	1.08e-04	8	289	3	ctd:C104525
Drug	silyloxide	F8 NSD1 NR5A2	1.08e-04	8	289	3	CID006327218
Drug	taxol	IL36A DAPK2 BAX BCL2 ACTL6A BIRC6 HPRT1 PKD1 SCN10A TOP3B ANXA5 MINK1 LAMB1 CASP8 XIAP REL CCT4 CCNB2 ATM	1.09e-04	560	289	19	CID000004666
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A	EXPH5 RABGAP1 GSE1 PLCL2 ASPM PLEKHA5 TRIOBP WDR59 FAM13A ELMO2	1.12e-04	181	289	10	1791_DN
Drug	richter	SPTBN2 LYST SACS CPEB1 MYBL1	1.13e-04	38	289	5	CID003032626
Drug	imexon	BCL2 ANXA5 CASP8 CCT4	1.28e-04	21	289	4	CID000068791
Drug	Bay K 8644	SST PKD1 CACNA1A CACNA1B CALML3 RGN ATP2C1 PRKAR1A ATP2A3	1.32e-04	150	289	9	CID000002303
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	RIBC2 MTSS1 BCL2 TBC1D16 SACS RANBP3 CASP8 RBM12 TBC1D31 FUT8	1.40e-04	186	289	10	3851_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; HL60; HT_HG-U133A	MTSS1 PIK3IP1 BIK CPNE3 PLEKHA5 DYNC2H1 CILK1 ATP10D FAM13A WDFY3	1.52e-04	188	289	10	1150_UP
Drug	AC1L2Q3W	BAX ANXA5 CCT4 RGN	1.55e-04	22	289	4	CID000126312
Drug	xanthorrhizol	BAX ANXA5 CASP8 CCT4	1.55e-04	22	289	4	CID000093135
Drug	tubeimoside I	BAX BCL2	1.61e-04	2	289	2	ctd:C051084
Drug	6-fluorocholesterol	LYST ATM	1.61e-04	2	289	2	CID000135206
Drug	25-fluorocholesterol	LYST ATM	1.61e-04	2	289	2	CID006454807
Drug	PT05	BAX BCL2	1.61e-04	2	289	2	CID000088927
Drug	polyaspartate	BAX BCL2	1.61e-04	2	289	2	ctd:C017645
Drug	((Py-3')TPP-Ru(phen)2Cl)Cl	BAX BCL2	1.61e-04	2	289	2	ctd:C547322
Drug	7-tricosene	TRRAP LYST	1.61e-04	2	289	2	CID006365493
Drug	G3-1	SST GAL	1.61e-04	2	289	2	CID000011643
Drug	furacridone	BAX BCL2	1.61e-04	2	289	2	CID005281842
Drug	yomogin	BAX ANXA5 CASP8	1.61e-04	9	289	3	CID000174865
Drug	SDDs	IFT172 CACNA1A LBP	1.61e-04	9	289	3	CID000087190
Drug	cagA protein, Helicobacter pylori	BAX BCL2 CASP8	1.61e-04	9	289	3	ctd:C080866
Drug	N,N-dimethylphytosphingosine	BAX BCL2 CASP8	1.61e-04	9	289	3	ctd:C542681
Drug	Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	BAX RANBP3 CPT1A ATP2C1 CELSR2 RCL1 MACF1 KDM2A ATM MYBL1	1.66e-04	190	289	10	7405_DN
Drug	pentabromodiphenyl ether	ZNF609 PDK3 TTC39C CYP17A1 MTSS1 BAX ETV6 NCF4 BCL2 SLFN5 TMCC3 HHATL CSDE1 PRRT3 ASPM CALD1 PDCD6 ANPEP IYD CASP8 CCT4 LBP CPT1A TEK GAL RBM12 RGS20 FAM13A NT5C2 DGKI CDH11 SNTB1	1.67e-04	1266	289	32	ctd:C086401
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; PC3; HT_HG-U133A	EPPK1 BCL2 GNL3L CALD1 REL CPT1A WDR59 KMO ATM ARHGAP33	1.73e-04	191	289	10	3811_DN
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A	PDK3 BAX AP2B1 SLC25A23 IPO5 CCDC22 TRIOBP LAMB1 ATP2C1 ATP2A3	1.81e-04	192	289	10	7427_DN
Drug	Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A	CYP17A1 MYOZ1 COPS8 CLEC11A CHPF2 CALD1 MINK1 WDR59 CSF1 WDFY3	1.81e-04	192	289	10	7191_UP
Drug	lanthanum chloride hydrate	CALML3 RGN ATP2C1 ATP2A3	1.86e-04	23	289	4	CID000165791
Drug	Enilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A	ZNF609 CYP17A1 ATP9B DBT SEMA4C ANK3 KMO ATP2C1 CELSR2 IL1RAP	1.89e-04	193	289	10	3139_DN
Drug	(S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; MCF7; HT_HG-U133A	IL36A DAPK2 BAX TYRP1 AKT3 MINK1 GRM1 CSF1 ATM WDFY3	1.89e-04	193	289	10	3870_UP
Drug	2-fluoroadenine arabinoside	BAX BCL2 F8 ANXA5 CASP8 XIAP REL NT5C2 ATM	1.95e-04	158	289	9	CID000003367
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	RABGAP1 SEMA4C SETDB1 KIF3B GNL3L RANBP3 YEATS2 MACF1 ATM QTRT1	1.97e-04	194	289	10	1670_DN
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A	ZNF609 RASSF2 ETV6 RABGAP1 GNL3L RANBP3 COBLL1 MINK1 CASP8 ATM	1.97e-04	194	289	10	5268_DN
Disease	sphingomyelin 14:0 measurement	PAK6 SYNE2 PAK5 THADA	1.94e-05	17	289	4	EFO_0010390
Disease	lymphocyte count	EPPK1 ACACA EXPH5 BAX BCL2 NIBAN3 LYST TBC1D16 JARID2 CILP2 ANTXR2 ACSBG1 CPNE1 AP3D1 CCHCR1 PLXDC1 COBLL1 MINK1 NSD1 JPH2 SAE1 CASP8 PBX4 GPRIN3 ACAD10 ARHGEF15 GTF2B THADA CSF1 PCDHGA12 ATM ARRDC2	2.03e-05	1464	289	32	EFO_0004587
Disease	prostate carcinoma	MYO6 EXPH5 C16orf78 ATP9B BCL2 BIK LONP1 CILP2 ANLN SYNE2 RPS6KL1 CCHCR1 NSD1 CASP8 PBX4 YEATS2 THADA CDYL2 INTS4 KDM2A ATM MAP3K21 DNAH11	2.65e-05	891	289	23	EFO_0001663
Disease	ataxia telangiectasia (is_implicated_in)	BAX BIK ATM	3.16e-05	7	289	3	DOID:12704 (is_implicated_in)
Disease	Global developmental delay	SPTBN2 ACTL6A TRRAP TBC1D20 CSDE1 CACNA1B NBAS AGO1	5.23e-05	133	289	8	C0557874
Disease	Rhizomelia	CILK1 LBR	9.56e-05	2	289	2	C1866730
Disease	fibroma	ANTXR2 GRM1	9.56e-05	2	289	2	C0016045
Disease	Fibromatosis	ANTXR2 GRM1	9.56e-05	2	289	2	C0016048
Disease	Mesomelia	CILK1 LBR	9.56e-05	2	289	2	C0549306
Disease	1-stearoylglycerol 1-monostearin measurement	SYNE2 KIAA1549	9.56e-05	2	289	2	EFO_0021111
Disease	Albinism	LYST AP3D1	9.56e-05	2	289	2	C0001916
Disease	Myxofibroma	ANTXR2 GRM1	9.56e-05	2	289	2	C0205766
Disease	hepatocellular carcinoma (biomarker_via_orthology)	BAX BCL2 HPRT1 CARM1 CASP8 TEK RGN	9.64e-05	108	289	7	DOID:684 (biomarker_via_orthology)
Disease	Esophageal Neoplasms	BAX BCL2 SST SERPINB3 CASP8 XIAP	1.19e-04	78	289	6	C0014859
Disease	Malignant neoplasm of esophagus	BAX BCL2 SST SERPINB3 CASP8 XIAP	1.19e-04	78	289	6	C0546837
Disease	Intellectual Disability	ACTL6A TRRAP TBC1D20 CSDE1 SACS SCN1A CACNA1B NSD1 PTPN23 SHANK3 AGO1 NT5C2 MACF1 FUT8	1.49e-04	447	289	14	C3714756
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	GABRG2 SCN1A SCN10A	1.92e-04	12	289	3	DOID:0060170 (implicated_via_orthology)
Disease	ADHD symptom measurement	CALD1 PBX4 LMOD2	1.92e-04	12	289	3	EFO_0007860
Disease	resting heart rate, chronic obstructive pulmonary disease	PLB1 SYNPO2L FUT8 CDH11	2.02e-04	30	289	4	EFO_0000341, EFO_0004351
Disease	ximenoylcarnitine (C26:1) measurement	CPNE3 CPT1A GAL	2.47e-04	13	289	3	EFO_0800543
Disease	nevus count, cutaneous melanoma	JARID2 TYRP1 TTC7B SYNE2 CASP8 ATM	2.78e-04	91	289	6	EFO_0000389, EFO_0004632
Disease	Familial hemiplegic migraine	SCN1A CACNA1A	2.85e-04	3	289	2	cv:C0338484
Disease	glycosyl ceramide (d16:1/24:1, d18:1/22:1) measurement	SYNE2 ATP10D	2.85e-04	3	289	2	EFO_0800530
Disease	Familial or sporadic hemiplegic migraine	SCN1A CACNA1A	2.85e-04	3	289	2	cv:CN295307
Disease	familial hemiplegic migraine 1 (implicated_via_orthology)	CACNA1A CACNA1B	2.85e-04	3	289	2	DOID:0111181 (implicated_via_orthology)
Disease	panic disorder	GARS1 ANO2 SDK2 IYD	2.95e-04	33	289	4	EFO_0004262
Disease	Spinocerebellar Ataxia Type 4	SPTBN2 CACNA1A PLEKHG4 GRM1	3.71e-04	35	289	4	C0752122
Disease	mean reticulocyte volume	ETV6 SYCE3 BCL2 TRRAP TBC1D16 LONP1 AP2B1 ACSBG1 PLCL2 VPS13A CPNE1 FLOT2 TXNDC11 THADA CHTF18 RCL1 INTS4 ATM IPO11	3.75e-04	799	289	19	EFO_0010701
Disease	macrophage inflammatory protein 1b measurement	GABRG2 ACACA SLFN5 AP2B1 QARS1 TOP3B ANK3	4.00e-04	136	289	7	EFO_0008219
Disease	Developmental delay (disorder)	SPTBN2 ACTL6A TBC1D20 NBAS	4.61e-04	37	289	4	C0424605
Disease	Neuralgia, Supraorbital	CYP17A1 SCN10A GAL	4.74e-04	16	289	3	C0038870
Disease	Paroxysmal Nerve Pain	CYP17A1 SCN10A GAL	4.74e-04	16	289	3	C0751373
Disease	Nerve Pain	CYP17A1 SCN10A GAL	4.74e-04	16	289	3	C0751372
Disease	Neuralgia, Ilioinguinal	CYP17A1 SCN10A GAL	4.74e-04	16	289	3	C0751371
Disease	Neuralgia	CYP17A1 SCN10A GAL	4.74e-04	16	289	3	C0027796
Disease	Neuralgia, Atypical	CYP17A1 SCN10A GAL	4.74e-04	16	289	3	C0234247
Disease	Neuralgia, Stump	CYP17A1 SCN10A GAL	4.74e-04	16	289	3	C0234249
Disease	Neuralgia, Iliohypogastric Nerve	CYP17A1 SCN10A GAL	4.74e-04	16	289	3	C0423712
Disease	Neuralgia, Perineal	CYP17A1 SCN10A GAL	4.74e-04	16	289	3	C0423711
Disease	Neuralgia, Vidian	CYP17A1 SCN10A GAL	4.74e-04	16	289	3	C0042656
Disease	brain glioma (biomarker_via_orthology)	BAX BCL2	5.66e-04	4	289	2	DOID:0060108 (biomarker_via_orthology)
Disease	spinocerebellar ataxia type 5 (implicated_via_orthology)	SPTBN2 SPTBN4	5.66e-04	4	289	2	DOID:0050882 (implicated_via_orthology)
Disease	abdominal obesity-metabolic syndrome 1 (biomarker_via_orthology)	BAX BCL2	5.66e-04	4	289	2	DOID:14221 (biomarker_via_orthology)
Disease	migraine (implicated_via_orthology)	CACNA1A CACNA1B	5.66e-04	4	289	2	DOID:6364 (implicated_via_orthology)
Disease	valerate measurement	TBC1D16 SGCZ	5.66e-04	4	289	2	EFO_0021112
Disease	Chediak-Higashi syndrome (implicated_via_orthology)	LYST WDFY3	5.66e-04	4	289	2	DOID:2935 (implicated_via_orthology)
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment	BCL2 SGCZ COBLL1 NSD1 LAMB1 FAM13A	5.99e-04	105	289	6	EFO_0007788, EFO_0008007, EFO_0008343
Disease	aspartate aminotransferase to alanine aminotransferase ratio	EPPK1 JARID2 CILP2 CPNE1 PRUNE2 ANPEP COBLL1 PBX4 CSF1	6.22e-04	239	289	9	EFO_0010934
Disease	familial atrial fibrillation	USP34 SYNPO2L MYOZ1 SYNE2 MYPN SCN10A SGCA	9.05e-04	156	289	7	C3468561
Disease	Persistent atrial fibrillation	USP34 SYNPO2L MYOZ1 SYNE2 MYPN SCN10A SGCA	9.05e-04	156	289	7	C2585653
Disease	Paroxysmal atrial fibrillation	USP34 SYNPO2L MYOZ1 SYNE2 MYPN SCN10A SGCA	9.05e-04	156	289	7	C0235480
Disease	brain glioma (implicated_via_orthology)	BAX BCL2	9.38e-04	5	289	2	DOID:0060108 (implicated_via_orthology)
Disease	leiomyoma (biomarker_via_orthology)	BAX BCL2	9.38e-04	5	289	2	DOID:127 (biomarker_via_orthology)
Disease	dementia (biomarker_via_orthology)	BAX BCL2	9.38e-04	5	289	2	DOID:1307 (biomarker_via_orthology)
Disease	response to trauma exposure, post-traumatic stress disorder symptom measurement	GPRIN3 GRID1	9.38e-04	5	289	2	EFO_0008483, EFO_0008535
Disease	atopy	PAK6 PAK5	9.38e-04	5	289	2	EFO_0002686
Disease	Atrial Fibrillation	USP34 SYNPO2L MYOZ1 SYNE2 MYPN SCN10A SGCA	1.05e-03	160	289	7	C0004238
Disease	epilepsy (implicated_via_orthology)	GABRG2 SCN1A SCN10A CACNA1A SLC12A6 CACNA1B MINK1	1.17e-03	163	289	7	DOID:1826 (implicated_via_orthology)
Disease	Schizophrenia	GABRG2 SPTBN2 BCL2 SST TRRAP JARID2 SETDB1 PLCL2 TOP3B IPO5 CACNA1B ANK3 GRID1 GRM1 LMOD2 SHANK3 KMO ATM FUT8	1.23e-03	883	289	19	C0036341
Disease	dilated cardiomyopathy (biomarker_via_orthology)	BAX BCL2 CASP8	1.25e-03	22	289	3	DOID:12930 (biomarker_via_orthology)
Disease	pulse pressure measurement	USP34 PDE8A CYP17A1 SYNPO2L RABGAP1 CILP2 STXBP2 COPS8 MYPN PKD1 SCN10A ASCC2 AP3D1 FLOT2 DYNC2H1 COBLL1 TRIOBP JPH2 PBX4 ACAD10 SPTBN4 GTF2B FAM13A NT5C2 CDYL2 CTNND1	1.32e-03	1392	289	26	EFO_0005763
Disease	VACTERL association (implicated_via_orthology)	IFT172 DYNC2H1	1.40e-03	6	289	2	DOID:14679 (implicated_via_orthology)
Disease	Lissencephaly	LAMB1 MACF1	1.40e-03	6	289	2	C0266463
Disease	Seizures	DBT SST TRRAP TBC1D20 AP3D1 CACNA1B MACF1 FUT8	1.46e-03	218	289	8	C0036572
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	SYNE2 COBLL1 MINK1 CPT1A CELSR2 MACF1	1.61e-03	127	289	6	EFO_0008595, EFO_0020947
Disease	Dyslipidemias	VNN1 NR5A2 DNAH11	1.62e-03	24	289	3	C0242339
Disease	Dyslipoproteinemias	VNN1 NR5A2 DNAH11	1.62e-03	24	289	3	C0598784
Disease	Colorectal Carcinoma	ACACA RASSF2 SPTBN2 OBSCN BCL2 PAK6 GSE1 SACS VPS13A CASP8 PBX4 GRID1 GRM1 GTF2B ATAD1 KDM2A	1.66e-03	702	289	16	C0009402
Disease	serum gamma-glutamyl transferase measurement	PLB1 SGSM1 IFT172 BCL2 GSE1 HPRT1 PKD1 CPNE1 GCN1 CALD1 ZSWIM5 COBLL1 TRIOBP CASP8 ARHGEF15 GTF2B THADA CELSR2 CATSPER2	1.82e-03	914	289	19	EFO_0004532
Disease	C-reactive protein measurement	USP34 IFT172 ETV6 USP20 CILP2 PKD1 GCN1 DAGLA CARM1 AKT3 ANK3 OLFML2B COBLL1 PBX4 DGKZ ATP9A FCRL6 YEATS2 CELSR2 SLC25A44 MACF1 ARHGAP33 DNAH11	1.91e-03	1206	289	23	EFO_0004458
Disease	Seizure, Febrile, Complex	GABRG2 SCN1A	1.94e-03	7	289	2	C0751057
Disease	able to hear with hearing aids	MYO6 PDCD6	1.94e-03	7	289	2	EFO_0009720
Disease	disease recurrence, response to allogeneic hematopoietic stem cell transplant, donor genotype effect measurement	PAK6 PAK5	1.94e-03	7	289	2	EFO_0004952, EFO_0007044, EFO_0007892
Disease	triglyceride measurement, multiple sclerosis	NCF4 SAE1	1.94e-03	7	289	2	EFO_0004530, MONDO_0005301
Disease	Seizure, Febrile, Simple	GABRG2 SCN1A	1.94e-03	7	289	2	C0149886
Disease	wellbeing measurement, smoking behaviour measurement	EXTL1 GRM1	1.94e-03	7	289	2	EFO_0005671, EFO_0007869
Disease	glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement	SYNE2 ATP10D	1.94e-03	7	289	2	EFO_0800551
Disease	hereditary ataxia (implicated_via_orthology)	CACNA1A CACNA1B	1.94e-03	7	289	2	DOID:0050951 (implicated_via_orthology)
Disease	atrioventricular septal defect (implicated_via_orthology)	IFT172 DNAH11	1.94e-03	7	289	2	DOID:0050651 (implicated_via_orthology)
Disease	non-alcoholic fatty liver disease	IL36A IFT172 BCL2 CPNE1 TARBP1 COBLL1 GPC6	2.19e-03	182	289	7	EFO_0003095
Disease	Malignant neoplasm of breast	RIBC2 CYP17A1 OBSCN BAX BCL2 SYNE2 MROH7 PLXNB1 PDCD6 DYNC2H1 ZSWIM5 UBR4 CASP8 CPT1A TEK CSF1 PRKAA1 HEATR9 MACF1 ATM ATP2A3	2.22e-03	1074	289	21	C0006142
Disease	waist-hip ratio	BCL2 BIRC6 GSE1 SYNE2 PKD1 AP3D1 PRUNE2 ANK3 DYNC2H1 ANXA5 COBLL1 NSD1 LAMB1 GPC6 YEATS2 GTF2B THADA FAM13A NR5A2 CDYL2 QTRT1 SNTB1 LRRC36	2.35e-03	1226	289	23	EFO_0004343
Disease	Cerebral Hemorrhage	BAX BCL2 CASP8	2.54e-03	28	289	3	C2937358
Disease	Multiple Organ Failure	SST LBP	2.57e-03	8	289	2	C0026766
Disease	microcephaly (is_implicated_in)	ASPM NSD1	2.57e-03	8	289	2	DOID:10907 (is_implicated_in)
Disease	cerebellar ataxia (implicated_via_orthology)	VPS13A CACNA1A	2.57e-03	8	289	2	DOID:0050753 (implicated_via_orthology)
Disease	Mental deterioration	TEK DGKI DNAH11	2.81e-03	29	289	3	HP_0001268
Disease	stomach cancer (is_marker_for)	BAX BCL2 GSE1 ASPM RGN ATM	2.82e-03	142	289	6	DOID:10534 (is_marker_for)
Disease	PROSTATE CANCER, HEREDITARY, 1	BCL2 CASP8 KDM2A ATM	2.86e-03	60	289	4	C4722327
Disease	Sclerocystic Ovaries	BAX BCL2 ANLN ASPM SPTBN4 MYBL1	3.03e-03	144	289	6	C1136382
Disease	Polycystic Ovary Syndrome	BAX BCL2 ANLN ASPM SPTBN4 MYBL1	3.03e-03	144	289	6	C0032460
Disease	Adenoid Cystic Carcinoma	ASPM NSD1 IGFBP2 ATM MYBL1	3.07e-03	100	289	5	C0010606
Disease	status epilepticus (biomarker_via_orthology)	BAX BCL2 ANK3 CASP8 ATM	3.07e-03	100	289	5	DOID:1824 (biomarker_via_orthology)
Disease	mean corpuscular hemoglobin concentration	GARS1 PHB2 ETV6 BCL2 LONP1 ACSBG1 HECW2 PLCL2 VPS13A ASCC2 FLOT2 COBLL1 ACAD10 LBR ARHGEF15 CHTF18 PRKAA1 RCL1 NT5C2 PRKAR1A MACF1	3.10e-03	1105	289	21	EFO_0004528
Disease	esophageal carcinoma	CASP8 ACAD10 IGFBP2	3.10e-03	30	289	3	EFO_0002916
Disease	Congenital adrenal hyperplasia	CYP17A1 PRKAR1A	3.29e-03	9	289	2	C0001627
Disease	pre-malignant neoplasm (implicated_via_orthology)	BAX CASP8	3.29e-03	9	289	2	DOID:0060071 (implicated_via_orthology)
Disease	Generalized Epilepsy with Febrile Seizures Plus	GABRG2 SCN1A	3.29e-03	9	289	2	C3502809
Disease	post-traumatic stress disorder (biomarker_via_orthology)	BAX BCL2	3.29e-03	9	289	2	DOID:2055 (biomarker_via_orthology)
Disease	Febrile Convulsions	GABRG2 SCN1A	3.29e-03	9	289	2	C0009952

Protein segments in the cluster

Peptide	Gene	Start	Entry
EMPLEITRSFIQNRD	C2orf42	451	Q9NWW7
RLLRMDLPVADDNTV	CACNA1A	1876	O00555
RLQEVSLRQGMRADP	CHTF18	521	Q8WVB6
MDTESNRRANLALPQ	MS4A2	1	Q01362
RDLIADSNPMVVANA	AP2B1	166	P63010
AVSRQLQDRLTPMEA	BIRC6	1476	Q9NR09
QEEQMQLPRADAIRS	CATSPER2	6	Q96P56
DINEMESPLATRNRT	NT5C2	496	P49902
RPQNLRLEMTAAKNT	AKAP4	171	Q5JQC9
VAAMRAINIADELPR	ABHD11	181	Q8NFV4
LMDLPRSASQLDARN	ADGRG6	846	Q86SQ4
APTLSQLDRNLDREM	ASCC2	511	Q9H1I8
PSQRDDISRLTVQME	DYNLT5	51	Q8N7M0
NPVSLMDNTLETRRA	GSE1	586	Q14687
DTQRISLEIMTLQPR	FLOT2	41	Q14254
MVLNVTVRETPGNRD	FCRL4	371	Q96PJ5
DTNALRVPRENMEAI	ACTL6A	71	O96019
EMTLERDVLQPLSRL	SH3BP1	116	Q9Y3L3
PDRQEEISRLMKNAS	AGO1	371	Q9UL18
VQQLAERFVSPEMRL	ANTXR2	66	P58335
RRQSIVLDPMLQEGT	C16orf78	151	Q8WTQ4
VRAMVDPAQTVEQRL	CPT1A	616	P50416
ETRQAIVNASRLPMS	CPNE3	436	O75131
QMVRQSTLELRLQPE	DNAH11	2136	Q96DT5
PSMASRVIDRAIQAF	ACAD10	1001	Q6JQN1
NPELTDGQIQAMLRR	ACACA	2236	Q13085
TLDDASAPRLMVLRQ	CSDE1	761	O75534
VIEMQLRALGREPAS	CCDC142	181	Q17RM4
LSPQERRMQESLFEV	ARHGEF15	411	O94989
NNRSIQLPTTVRDIM	ANPEP	526	P15144
RALDNNRPLEAIMSV	CELSR2	1086	Q9HCU4
RMLVVLLQANRDPDA	ANXA5	151	P08758
DANEPVSLEARLSRM	ANO2	76	Q9NQ90
QLMSELETLPRDVSR	CCDC22	476	O60826
VIRMQPTNRCLSTLE	DTWD2	211	Q8NBA8
DEMDVSLRAPRLAQL	BIK	66	Q13323
SLRAPRLAQLSEVAM	BIK	71	Q13323
LAVDVQMQSITRRGP	CACNA1B	1971	Q00975
ALAMQPLRSENAQLR	CCDC14	481	Q49A88
SDPEQMRQSLLTAIR	COBLL1	1076	Q53SF7
LRRDNMEEITNPLQA	ASPM	3451	Q8IZT6
AENPAMTRELLRAQV	ARMCX3	271	Q9UH62
LPRAAVVQTQTFMAR	ARRDC2	216	Q8TBH0
MARKNAIVRSLPSVE	ATP2A3	326	Q93084
RELRDNVITPRDTTM	ATP2C1	796	P98194
RVSLMPLRLNIDQDA	ATG2B	1701	Q96BY7
QCTLRSRTPEQVMVD	ATP10D	741	Q9P241
RQEEERMNCSPTSQI	AKT3	111	Q9Y243
LSVLDSLNARMARPQ	AP3D1	966	O14617
RAPRTQAMEEQLVST	MROH7	1116	Q68CQ1
SPQMANRIVDSARSI	RCL1	201	Q9Y2P8
LRSRVEQEQEAKMPA	RANBP3	511	Q9H6Z4
LSPQDTFEALKRNRM	RBM12	351	Q9NTZ6
MNSRRREPITLQDPE	CYB5R2	1	Q6BCY4
PLRRLQDLASMINVE	NSD1	71	Q96L73
RAALVMDLIDLTPRQ	NSD1	2451	Q96L73
MIRQRLEEIAETPAT	RASSF2	311	P50749
PVVNLARSLRMQEEG	RAB44	986	Q7Z6P3
RNILRSDTDVSMPLV	C9orf64	131	Q5T6V5
DQDPRVRTAAIKAML	INTS4	206	Q96HW7
ARIRVMVLDANDNAP	PCDHGA12	226	O60330
RPDTVRNLVQSMQVL	PTPN23	431	Q9H3S7
QDRAVPSLAMILVNS	LBR	411	Q14739
TAVLMREQLPALRAQ	NIBAN3	271	Q86XR2
EMRRLIAQIVASDPD	YOD1	181	Q5VVQ6
RLENMSPRQVVERSA	KIAA1107	136	Q9UPP5
RRAQMQIDKILDPTA	KIAA1549	1566	Q9HCM3
IRRTMTNERPEENTN	HECW2	866	Q9P2P5
TLATPAVRRLAMENN	DBT	171	P11182
FLDLMLVREPSQRAT	PAK5	676	Q9P286
ASVNAPRSEVEALRM	RABGAP1	156	Q9Y3P9
DNMIRRLSPAERAQG	ETV6	206	P41212
TNPNLLLMERASTRD	FAM166C	76	A6NJV1
ERMLVRDPQERATAQ	PAK6	636	Q9NQU5
ARPATERMAIEALQA	JPH2	536	Q9BR39
SLVEAPRATAQMLEV	LBP	231	P18428
PLARIEASLSVQMSR	HHATL	411	Q9HCP6
NMPLTRESSVRQIIA	HSFY1	246	Q96LI6
TVRSLLQPQEDDRVM	TRIM71	446	Q2Q1W2
AEEDMPQRVVLLQRS	MDC1	431	Q14676
TMRQIQVFEDEPARI	IL1RAP	31	Q9NPH3
ALRRLESMLQPLAQE	FYCO1	336	Q9BQS8
RENLQRKMAERPTAA	ANLN	16	Q9NQW6
ADVRPTLEMLRNAGI	ATP9B	746	O43861
MDNITQPERRKLSAL	IPO11	836	Q9UI26
TPQRSAHENLMEAIR	LMOD2	516	Q6P5Q4
RQPVVDTFDIRILMA	CARM1	336	Q86X55
NMRSRTLQEPLSDCE	FCRL6	416	Q6DN72
LRERLNVLEAEMSPQ	CCDC194	181	A0A1B0GVG4
NVLEAEMSPQRRVPR	CCDC194	186	A0A1B0GVG4
NPVTVRSIISMFDRE	PDCD6	61	O75340
VAAMSPANISREETR	PLXNB1	536	O43157
LDQVLERISTMRLPD	IGFBP2	231	P18065
LGTQTQEVARREMPS	LRRC36	231	Q1X8D7
AAEEAQRPRSMTVSA	MTSS1	451	O43312
QEVINTMLRTPENRT	PDE8A	701	O60658
INMSSLPAQDKIRSR	NCBP3	176	Q53F19
EDVALMVRQARGLPS	NCF4	301	Q15080
RNPKSRMEELDISNV	LRRC74A	356	Q0VAA2
EPRELPQRSQEANMT	EXPH5	1536	Q8NEV8
EPNSTVEQSALMRDR	LAMB1	1341	P07942
RPVRQNLAMTGEVSL	LONP1	871	P36776
DTLPGLVMAQDQRIR	F8	1946	P00451
SPRLMDEAVLALRNL	GCN1	311	Q92616
RLVTREEFAIMQTPA	GCN1	756	Q92616
IMPIVQRAFQDRSTD	GCN1	1616	Q92616
NQRVPADMIFLRTSE	ATP9A	166	O75110
SPLELIRAQANRMAE	KIAA1191	251	Q96A73
IRAQANRMAEDPAAL	KIAA1191	256	Q96A73
REMQRITLPLSAFTN	PIK3IP1	211	Q96FE7
MQDQEHPSIRTLSAR	IPO5	181	O00410
IAAARILQNMDPTTE	MMEL1	96	Q495T6
MVSVATLLREDANLP	MMEL1	281	Q495T6
MAVALPRDLRQDANL	RIBC2	6	Q9H4K1
ISEEDLTPRMRQRSN	FAM13A	726	O94988
QPELLRFRMTQLTVE	NBAS	826	A2RRP1
MVNISLRVLSRPNAQ	PHB2	101	Q99623
ESLPHDMQRNVSVLR	ING2	36	Q9H160
DSPGIVSQELRMALR	LIX1	216	Q8N485
VVAEQMSRLTPERNL	MACF1	1226	Q9UPN3
EPMLETLENLSSRLR	MACF1	5901	Q9UPN3
NRNSDRSIPMTVDFI	HPRT1	86	P00492
TVSMDQRLEQVLPRD	IFT172	1651	Q9UG01
AEQTRLMPAEQRDSN	PASD1	756	Q8IV76
DSKDQQLMVALRVRP	KIF19	6	Q2TAC6
ARASAELRIQSPMLQ	OBSCN	6191	Q5VST9
NPVVSRINMRIQDLT	P4HA1	391	P13674
VLQDMEDPRRAASSL	POU2AF1	216	Q16633
RSPEARAQEALNAMI	PLEKHG6	326	Q3KR16
VTNLLQEQSRMRPVS	PBX4	156	Q9BYU1
PARLMALALAERAQQ	ARHGAP33	896	O14559
LVVQALRPDRLQSAM	DYNC2H1	3676	Q8NCM8
INQRPSCIMDVSLRS	ATM	1476	Q13315
AFLTASPEQVRAMER	FBH1	1011	Q8NFZ0
QDQTLIAVPRKDRMS	IL36A	26	Q9UHA7
VDITRPDTFIRQQIM	GPC6	451	Q9Y625
LEFSHTRLENMVQRP	KDM2A	146	Q9Y2K7
TRLENMVQRPSTVDF	KDM2A	151	Q9Y2K7
LEDQIVSQGIPMRAR	KMO	71	O15229
TMRFRDNTPNAIAIV	CSF1	96	P09603
VLRMERFEPQIQATE	GK2	481	Q14410
MALLRRPTVSSDLEN	CCNB2	1	O95067
MELSRQPEIVARLQA	CYP46A1	316	Q9Y6A2
QLAISPSRAARQLME	ELMO2	76	Q96JJ3
ATLDPALQAMRAAIE	CROCC2	396	H7BZ55
TPVDNQQAMVRRESV	DAPK2	286	Q9UIK4
LAPAMIRISLRNQAN	DGKI	686	O75912
LQALNPNRLSAMREA	FAM163B	141	P0C2L3
MLRAPRAQAAVEDVL	FCRL1	211	Q96LA6
DPIVNRLLRSMATQA	DIS3L	751	Q8TF46
SFDRSIPENNIMRTI	GAL	76	P22466
LQRMIAAVDTDSPRE	BAX	76	Q07812
RPQMATLDIASNNRK	CYP17A1	96	P05093
DIRPRSATIQMNNAT	GABRG2	381	P18507
LMAQAVDRDTNRPLE	CDH11	126	P55287
SRETPQESRQDMIVR	ACSBG1	21	Q96GR2
RRMPRSNSQENVEAS	APBA1	561	Q02410
PVRVADERRMLSSNI	ANK3	2961	Q12955
VSERRLDTQRPQVTM	CCHCR1	46	Q8TD31
PASMRIRELNLSNCV	FBXL13	476	Q8NEE6
MERELQTPGRAQISA	CASP8	86	Q14790
TEEPVALIQRMLFRT	LYST	316	Q99698
LTSMCQPREQARESL	FBXO40	681	Q9UH90
LAAELQARRAPLATM	DAGLA	766	Q9Y4D2
QARRAPLATMESLSD	DAGLA	771	Q9Y4D2
LTVSRMDNPIRTFQD	GRID1	656	Q9ULK0
KMLERVRSQPLTNDD	KHDC1L	101	Q5JSQ8
EIALLMNRPRAATVV	PRKAR1A	326	P10644
TVQPIMEALRDATRR	COPS8	101	Q99627
VMRSLGQNPTEAELR	CALML3	36	P27482
SRMDQEQAALAAVTP	CPEB1	231	Q9BZB8
PQVERALAAVERQMA	GJA4	121	P35212
PEQLRIQVSRVSMHD	DGKZ	641	Q13574
RALRPDQMISDQLAT	FAM186A	216	A6NE01
IVDNVRPDRQTVMFS	DDX46	546	Q7L014
RMAVDLPQDISNKRT	GPATCH2	166	Q9NW75
PEDSLMRSQRTSNRE	GPRIN3	151	Q6ZVF9
FLRVVPSDTLQARAM	GRM1	201	Q13255
DTRPKVSSLLNRMAN	SLC12A6	141	Q9UHW9
ERQRAREMTEVLPSQ	SEC14L6	326	B5MCN3
PMVQQEDVRARSVLL	SDK2	1406	Q58EX2
QMRRSSLPATDAALI	SPACA1	206	Q9HBV2
QIPNDRFTSEVAMRV	SACS	4546	Q9NZJ4
QRERLPVTDDLQMAQ	PRRT3	106	Q5FWE3
LERVRVSPQDANPLM	CTNND1	41	O60716
MSAENEVRRKRIPSQ	MYBL1	276	P10243
TREAVVRASNLPMSV	CPNE1	431	Q99829
PVFDEIILSTARMNR	D2HGDH	141	Q8N465
RPLNDMKQELTTEFR	IFNE	191	Q86WN2
MVDSPAVQRFLVSRV	PKD1	446	P98161
RSVRFISNEQVPMEV	IYD	101	Q6PHW0
ADMLRIPRTAQDRLA	JARID2	681	Q92833
PLRQRVDTMENSAIK	PPEF1	461	O14829
MVVQRTPEEERNLLH	MINK1	886	Q8N4C8
DNLVSPVRALAMEAL	MROH2A	866	A6NES4
LRLPEIRAISMQAEE	NR5A2	501	O00482
QNEDLRRMAESLRIP	FUT8	56	Q9BYC5
LNDTAPRAMAVLESL	QARS1	561	P47897
STQELARVEPAAMLN	SYNPO2L	401	Q9H987
VTRSMALADPENRQL	SNTB1	251	Q13884
MLDVEALALRPVNAS	SUSD5	441	O60279
SRLQMILNEIQPRDT	THADA	986	Q6YHU6
TQASLESAPRIMRLV	QTRT1	6	Q9BXR0
EMDPSTQISLNRRAV	TBC1D31	1016	Q96DN5
EVINRRCPEMVSNSR	PRUNE2	351	Q8WUY3
RVERHDMNTLSLPLN	TMCC3	26	Q9ULS5
SVMIIAATNRPDVLD	SPATA5L1	621	Q9BVQ7
SLPQIQRMADDVVAI	SYNE2	3881	Q8WXH0
AANASSPQMSELRRE	TMEM200B	86	Q69YZ2
MPRLRAIQLTSDESN	MAP3K21	551	Q5TCX8
AESAEIPNTAERMQR	NBPF6	621	Q5VWK0
DPRSLNRLQLVLAEM	PLEKHG4	726	Q58EX7
SSSNLNPREVMEAVR	PSG6	151	Q00889
SRVREVINRNMVEPS	RGS20	331	O76081
SILESIINDMRDLPN	TAF1L	1406	Q8IZX4
DRRSVLQRIMETDPL	GNL3L	521	Q9NVN8
PIRDATDLRENMQNA	PLCL2	926	Q9UPR0
ETQRQADIMLPALRS	EPPK1	871	P58107
SMRQIRAEISELPSI	GARS1	691	P41250
RMSPQAREDQLQRKA	POP4	41	O95707
RLRMVTNTIEENFPL	SIMC1	471	Q8NDZ2
MSRPVELSDRETLLN	CCT4	151	P50991
RAEASLERAQNLNPM	SAE1	91	Q9UBE0
LVTARPTAVNMARAA	MRI1	86	Q9BV20
QDLRLESPTRSLIME	SGCZ	191	Q96LD1
RVTMDAPVSSVALRQ	RGN	51	Q15493
ASILTNPMDVIRTRV	SLC25A44	236	Q96H78
PVQARRLVDLMKNDT	PLB1	481	Q6P1J6
DARLQALVVMAAQPR	SEMA4C	606	Q9C0C4
VNTLRRIQASMAPAA	SERTAD1	71	Q9UHV2
SMPDIRSALQRDAAA	OLFML2B	221	Q68BL8
RLANTMREVNLLPDN	PDK3	56	Q15120
SLQNMRETRVDLHLP	SERPINB3	271	P29508
LQVLAALQEMSPARV	EXTL1	326	Q92935
ALQEMSPARVLALRQ	EXTL1	331	Q92935
TEELRQMAASREVPR	SGCA	341	Q16586
TMLPAKQAELTRRSQ	TRIOBP	1356	Q9H2D6
RRLMASAQSNPDDVL	SETDB1	1086	Q15047
DPSQRQRAMSIASIL	SCN1A	706	P35498
IRSQSRPNDIMAEVC	PRKAA1	411	Q13131
SVNREMSPLVDNIAL	BCL2	161	P10415
TDASLSLPSRRMQND	CALD1	126	Q05682
ATNRPQDLDSAIMRR	ATAD1	236	Q8NBU5
DNNALTPEIMKEVRR	CDYL2	271	Q8N8U2
VQRMPSQISLRDLSE	CLNK	196	Q7Z7G1
PNASSEAVQLLRDML	CILK1	251	Q9UPZ9
DQRQVDRTLVTIMPQ	CILP2	1001	Q8IUL8
LAQPADRQQMEALTR	CLEC11A	211	Q9Y240
VRAEAPSQVRLMDVV	CHPF2	566	Q9P2E5
VAMTLETKPQRRDQR	CHRD	451	Q9H2X0
QRPLALNTVEMLRVA	TOP3B	296	O95985
NADARNTTMVLDVLP	URGCP	126	Q8TCY9
AQMLVALSAVESREP	TMEM86A	216	Q8N2M4
TLSRAVRTMQNLFPE	TTLL11	286	Q8NHH1
DLTQQCRRTLMEQPL	TXNDC16	221	Q9P2K2
IRARRSMDEANQPLL	TYRP1	501	P17643
RMLTLITEQFVADPR	ZSWIM5	381	Q9P217
TAVNPRLLENQARAM	nan	11	Q6ZUT4
MRPSETEINAKLRNI	VPS13A	1086	Q96RL7
SLTRRIDDTIFQNPM	XIAP	361	P98170
LTPVSREEALALMNR	VNN1	41	O95497
ASQALEPMVLREFLR	WDFY3	931	Q8IZQ1
VNLQMDAQERPRDVS	SPTBN2	1926	O15020
KVRLQSQRPSMASEL	SLC25A39	36	Q9BZJ4
QKRARSMIILQDSAP	SHANK3	886	Q9BYB0
ITTMADRINLPRNIV	GTF2B	121	Q00403
RAENIVLLELDMPSR	KIF3B	656	O15066
LDEPFRAQRAMSVVS	SCN10A	601	Q9Y5Y9
TNPTLAESMRRLEDA	SYCE3	51	A1L190
TRSQLLIMDRAADPV	STXBP2	226	Q15833
IPVQLQRSMAAEAEA	STOML3	196	Q8TAV4
ILVVAQSVPDRMLAS	TBC1D16	141	Q8TBP0
LMNPDATARQEAVIS	HEATR9	411	A2RTY3
NARTELDSPRDLMVT	TNR	681	Q92752
NDISSPCEQIMVRTR	ZNF609	271	O15014
RNLSQEESMEAPIRV	SH2D7	206	A6NKC9
VQERLPLAMQTERGN	SPTBN4	1531	Q9H254
EQIRNRVALGVPDMT	RPS6KL1	31	Q9Y6S9
MESQRDLSLVPERLQ	TBCC	16	Q15814
SVLDPRDLRQLHQMS	REL	526	Q04864
MASAPAEAETRQRLL	SGSM1	1	Q2NKQ1
ERPSFAQILVSLNRM	TEK	1081	Q02763
RLDVNQADIAPLMTS	PIGN	316	O95427
VTADVINPMALRQRE	SART1	151	O43290
RERQQVVSLAAMREP	USP20	691	Q9Y2K6
RRADVILSDMAPNAT	MRM2	146	Q9UI43
SNGLVTVMVPQLRRE	WDR59	246	Q6PJI9
QLARNLPMDTFTVAR	TXNDC11	731	Q6PKC3
VTMPIRAAELTRANL	ZNF507	501	Q8TCN5
ESMANRDAVLSRIPE	TTC7B	336	Q86TV6
PLALVRTRMQAQASI	SLC25A23	396	Q9BV35
EQMAFLSPEQRRAVA	STRCP1	1716	A6NGW2
NSDPTDVAALRRMAI	TBC1D20	41	Q96BZ9
AVQMPIRTLQSALEA	TARBP1	921	Q13395
TLAMDTLPDNRTRVV	PLXDC1	71	Q8IUK5
VFNTESLPSVDNRMR	USP34	676	Q70CQ2
SAPSMVDRLQRQIII	TTC39C	121	Q8N584
MDLRTERPRSAVEQL	PLEKHA5	876	Q9HAU0
RQLMCLLTRDNPEAT	UBR4	3926	Q5T4S7
ARAIVRQAMAILTPA	TRRAP	1916	Q9Y4A5
VTLGTQQRQEMDPRL	SLFN5	21	Q08AF3
EMRLELQRSANSNPA	SST	81	P61278
PDRGTLQVLQDMASR	TKTL1	16	P51854
SRAAQMAVPSSRILQ	THEG	256	Q9P2T0
AEQQMPLEPVRARLS	TXNRD3NB	16	Q6F5E7
IEERLSNNMEQRPSR	YEATS2	161	Q9ULM3
RAEDLPMRNTVALLQ	LRRC14	201	Q15048
AAQIPARQREIEMNR	MYO6	1161	Q9UM54
PRDVMLEELSLLTNR	MYOZ1	41	Q9NP98
ADETQARKRLSPDQM	MYPN	91	Q86TC9